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 Neurodevelopmental disorders such as ADHD represent a major national 
problem. There are increasing numbers of students in schools requiring special education 
services as a result of ADHD, and each of these students costs the U.S. education system 
approximately $5,000 per year (Robb et al., 2011). There are additional societal costs 
associated with the disorder, and ADHD can be debilitating for individuals with the 
disorder and their families (i.e., Barkley & Murphy, 2010; Ginsberg, et al., 2013). The 
most common treatments are stimulant medication and behavioral training (i.e., Pelham 
& Fabiano, 2008), but recently neurofeedback (EEG biofeedback) has been receiving a 
lot of press. Both the American Academy of Pediatrics and the American Academy of 
Child and Adolescent Psychiatry have endorsed neurofeedback as a viable option for the 
treatment of ADHD (AAP, 2012; Lofthouse, et al., 2012). Methods: The current study is 
a randomized controlled study investigating the effects of LORETA neurofeedback on a 
college population with ADHD. The study used a pre-test, multiple post-test design with 
delayed treatment to provide stronger evidence of its effectiveness. Both qEEG and 
behavioral data were collected to determine if there were changes in brain activity, and if 
these changes were evident on popular measures of cognitive ability (i.e., Woodcock-
Johnson III) and attention (CPT-II). Results: The results indicated that following 
LORETA neurofeedback treatment, participants exhibited significant changes in z-score 
qEEG coherence within the prefrontal cortex. These changes were also related to changes 
in performance on a verbal working memory measure, which approached significance. 
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Neurodevelopmental disorders such as attention deficit hyperactivity disorder 
(ADHD) represent a major national problem. First, there is a high prevalence of these 
disorders in schools. In fact, according to the US Census Bureau’s American Community 
Survey (ACS, 2006; Brault, 2008), an estimated 6.3% of children ages 5-15 have a 
disability, which amounts to 2.8 million children in the United States. Of those, many are 
children who are diagnosed with ADHD, and receive special education services under the 
Individuals with Disabilities Education Improvement Act (IDEIA 2004). There are 
increasing numbers of students in schools requiring special education services as a result 
of this disorder, and each student diagnosed with ADHD costs the U.S. education system 
an average of approximately $5,000 per year versus students without, who cost, on 
average, approximately $300 each (Robb, Sibley, Pelham, Foster, Molina, Gnagy, et al., 
2011). Additionally, some studies have shown a relationship between ADHD and societal 
costs such as those related to criminality and accidents (Bernfort, Nordfeldt, & Persson, 
2008; Ginsberg, Långström, Larsson, & Lichtenstein, 2013; Matza, Paramore, & Prasad, 
2005). In fact, the annual societal cost of an individual with ADHD is close to $15,000 
(Pelham, Foster, & Robb, 2007). In addition to financial and societal concerns, ADHD 
can be debilitating for individuals with the disorder. While behavioral therapies and 
stimulant medications have historically demonstrated success for the treatment of ADHD, 
both treatments have also demonstrated differential effectiveness in terms of identifying
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 responders and non-responders (i.e., Elliott, et al., 2014; Lauth, Minsel, & Koch, 2015). 
Finally, drug therapies can be risky, particularly considering the impacts of long-term use 
(i.e., Wang, et al., 2013), suggesting a need for more and better treatment options. 
Diagnosis and Impairment 
According to the current Diagnostic and Statistical Manual of Mental Disorders 
(DSM-V; APA, 2013), the key feature of ADHD is a persistent pattern of behavior (i.e., 
inattention, hyperactivity and/or impulsivity) that is developmentally inappropriate. 
Historically there are three prominent theories of ADHD—Barkley’s Behavioral 
Inhibition Model, the ADHD/I-ADHD/C dichotomy, and more recently, a working 
memory model—that attempt to explain the underlying causal mechanisms of the 
disorder (Barkley, 2003; Kofler, et al., 2010; Milich, et al., 2001; Raiker et al., 2012). 
Regardless of the theory to which one subscribes, all three include an emphasis on 
cognitive processing as a primary concern of the disorder. As cognition is an important 
facet of everyday life, it is not surprising that individuals with ADHD experience 
impairment in many areas. Indeed, the DSM-V criteria require clinically significant 
impairment in daily functioning (e.g., social, academic, occupational functioning) across 
two or more settings.  
One way in which this manifests is in social functioning. Children and 
adolescents with ADHD often experience social isolation, in that they are often rejected 
by their peers (McConaughy, Volpe, Antshel, Gordon, & Eiraldi, 2011). Research has 
also demonstrated that children with ADHD tend to have lower academic achievement 
performance than their non-ADHD peers (Frazier, Youngstrom, Glutting, and Watkins, 
2007; McConaughy, et al., 2011). Furthermore, studies have demonstrated that the 
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difficulties associated with ADHD continue into adulthood (Barkley, Murphy, & Fischer, 
2010; Buitelaar, Kan, & Asherson, 2011). For instance, two meta-analyses found that 
individuals with ADHD tend to have lower rated self-esteem, lower educational 
outcomes, lower occupational status and job performance ratings, as well as less job 
stability than their non-ADHD peers.  Additionally, individuals with ADHD consistently 
have higher medical billing costs, and are at elevated risk for developing comorbid 
psychiatric disorders, most notably substance use disorders (Bernfort, et al., 2008; Matza, 
et al., 2005).  
As previous research has shown, although the characteristics of the disorder may 
change as an individual ages, ADHD can still impact an individual’s daily life into 
adulthood (Barkley & Murphy, 2010; Barkley, Murphy, & Fischer, 2010; de Graaf et al., 
2008; Halmoy, Fasmer, Gillberg, & Haavik, 2009; Painter, Prevatt, & Welles, 2008). In 
fact, symptoms of ADHD are estimated to affect five to eight percent of the general 
population across the lifespan (Goldstein, 2011), and two to eight percent of college 
students (Fleming & McMahon, 2012). As ADHD is often diagnosed in childhood, the 
majority of the literature base is focused on children. Although recently there has been a 
shift towards researching ADHD in adults, there is still a lack of well-established 
research for college students with the disorder (Fleming & McMahon, 2012). 
Adolescence and emerging adulthood are times of great personal growth and identity 
development, which often times is accompanied by experimentation (Schlegel, 2012). As 
such, risk-taking behaviors are often studied in adolescent and college populations. 
Moreover, research has demonstrated a link between risk taking behaviors and executive 
functions in this young-adult population (Pharo, Sim, Graham, Gross, & Hayne, 2011; 
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Steinberg, 2007). Executive dysfunction, specifically, impulsivity, is also one of the core 
cognitive deficits associated with ADHD. Thus, if non-clinical populations of college 
students demonstrate an affinity towards risky behaviors, and individuals with ADHD are 
at increased risk for engaging in risky behaviors, college students with ADHD are at even 
higher risk. Specifically, inattention and poor impulse control may be highly problematic 
for college students with ADHD, who endure long lectures, must organize their time and 
effort to study, and are exposed to a wide variety of risky situations, such as those 
associated with drinking and sexual activity (Barkley et al., 2002; Weyandt & 
DuPaul,2008).  
Current Treatment 
Like many mental health disorders, there is no cure for ADHD. Currently, the two 
most widely accepted treatments for ADHD are stimulant medication and behavioral 
modification, or some combination thereof (National Dissemination Center for Children 
with Disabilities [NICHCY], 2011; National Institute of Mental Health [NIMH], 2008). 
In 2008, Pelham and Fabiano reviewed 46 studies that evaluated a variety of behavioral 
evidence-based interventions (EBI) for ADHD, concluding that behavioral parent 
training, behavioral classroom management, and behavioral peer interventions (i.e., social 
skills training) are well-established EBIs for ADHD. Additionally, the National Registry 
of Evidence-based Programs and Practices lists four empirically supported (behavior-
based) treatment programs for ADHD; however, none of these interventions have been 
researched with a college population.  
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ADHD and Neuroimaging 
Furthermore, disorders such as ADHD are neurological in nature. In fact, several 
studies utilizing positron emission tomography (PET), magnetic resonance imaging 
(MRI), and functional magnetic resonance imaging (fMRI) have demonstrated structural 
and/ or functional brain differences in individuals with ADHD (i.e., Castellanos, Giedd, 
Marsh, Hamburger, Vaituzis, & Dickstein, 1996; Fonseca, Tedrus, Moraes, Machado, 
Almeida, & Oliveira, 2008; Koehler, Lauer, Schreppel, Jacob, Heine, Boreatti-Hümmer, 
et al., 2009; Monastra, Lubar, Linden, VanDeusen, Green, Wing, et al., 1999; Semrud-
Clikeman, Steingard, Filipek, Biederman, Bejjen, Renshaw, 2000; and Vaiyda, Bunge, 
Dudukovic, Zalecki, Elliott, & Gabrieli, 2005).  
One such PET study examined dopamine transporter (DAT) dysregulation in 
adults with ADHD (Spencer et al., 2007). The sample consisted of 47 adults (21 clinical, 
26 control), and the final analyses were corrected for age, as the non-clinical group was 
significantly younger than the clinical group. After correcting for age, the results of the 
study suggested that DAT binding was 15% greater in the right caudate for the ADHD 
group than the control group  
(t = 7.7, df = 45, p = .008). Additionally, given that sex can moderate DAT binding, the 
authors reanalyzed the data simultaneously controlling for both age and sex. The results 
suggested an even larger effect in the right caudate, with 17% greater DAT binding in 
males (t = 6.9, df = 24, p = .02) and 22% in females (t = 7.3, df = 21, p = .02).  
Similarly, a meta-analysis of 21 MRI studies of children (ages 9-14) with ADHD, 
found a number of structural differences (Valera, Faraone, Murray, & Seidman, 2007). 
Across these 21 studies, the most frequently assessed variable was total cerebral volume, 
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which was measured in 8 studies, and demonstrated global volumetric reduction across 
studies. Indeed, there were 9 regions of interest—including total cerebral volume —that 
demonstrated significant change between ADHD and control subjects across 3 or more 
studies, and another 6 areas, which demonstrated significant differences between the 
clinical group and controls in at least 2 studies. The areas found to be impacted the most 
included: total cerebral volume, the corpus callosum, caudate, and cerebellum, as well as 
the prefrontal cortex, frontal lobes, and deep frontal white matter. Notably, the right 
caudate, which was implicated in the PET study described above, was found to 
demonstrate significant standardized mean differences in 6 of the 21 studies.   
Another more recent review article (Friedman & Rapoport, 2015) supports 
numerous structural differences between individuals with ADHD and controls. Similar to 
the 2007 meta-analysis, this study reports volumetric loss in the right striatum as a key 
feature of ADHD. In addition, the authors cite other studies, which have shown 
significant volume loss in the prefrontal cortex (PFC), parieto-temporal areas, basal 
ganglia, and cerebellum (i.e., Nakao, et al., 2011; Valera, et al., 2007). Lastly, the authors 
cite atypical brain development, which affects attention, cognitive control, and working 
memory processes. This is consistent with the previous meta-analytic study, suggesting 
that structural changes are particularly notable in the cerebellum, PFC, and right 
hemisphere for individuals with ADHD. 
Finally, a recent meta-analysis was conducted, comparing 55 fMRI studies of 
individuals with ADHD (Cortese, Chabernaud, Proal, Di Martino, Milham, & 
Castellanos, 2012). Of these, 39 studies focused on children, and the other 16 examined 
adults with ADHD. The authors used activation likelihood estimation for the meta-
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analysis.  Results indicated that children with ADHD exhibited bilateral hypoactivation in 
the frontal regions and putamen, as well as the right parietal and temporal regions, and 
hyperactivation in the right angular gyrus, middle occipital gyrus, posterior cingulate 
cortex, and midcingulate cortex.  Results of the adult analyses indicated hypoactivation in 
the middle frontal gyrus, right central sulcus, and precentral gyrus, and hyperactivation in 
the right angular gyrus and middle occipital gyrus. This suggests that both regional 
hypoactivation and hyperactivation persist into adulthood for individuals with ADHD. At 
minimum, frontal hypoactivation and hyperactivation of the right angular gyrus and 
middle occipital gyrus seem to exist in both child and adult clinical populations when 
compared to non-ADHD peers. 
ADHD and QEEG 
Overwhelmingly, PET, MRI, and fMRI research has suggested the existence of 
both structural and functional differences in the brains of individuals with ADHD. 
Studies examining differences between ADHD and non-ADHD populations using EEG 
have paralleled these results, thus demonstrating the utility of EEG and/or quantitative 
EEG (qEEG) in diagnostic clinical evaluations for ADHD. For example, Fonseca and 
colleagues (2008) demonstrated differences in electroencephalographic activity between 
children with ADHD and age-matched controls during an eyes closed resting state. Data 
was recorded from 15 electrode sites in this study, and the authors examined absolute and 
relative power across the frequency bands. First, the ADHD group exhibited greater 
absolute power in delta and theta bands across the brain. Second, this group exhibited 
greater absolute power in beta around the midline (i.e., C3, F4, C4 F0, C0, and P0). 
Third, the ADHD group exhibited smaller relative power in the alpha 1 and beta bands at 
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certain electrode sites (i.e., O1, F4; T6 respectively). Overall, the study found that qEEG 
provided 83.3% sensitivity and 83.3% specificity in the diagnosis of ADHD. Another 
study examined EEG differences in adults with ADHD (Koehler, et al., 2009). Koehler 
and colleagues (2009) recorded data from 21 electrodes, and also examined absolute 
power densities. In this study, the ADHD sample exhibited increased absolute power in 
the alpha and theta bands, with no differences in beta. This suggests that the patterns of 
activation, while still abnormal, may change as individuals age. 
A 2015 study (Snyder, et al., 2015) examined the integration of EEG markers 
(i.e., theta/beta ratio) with clinical judgment in the diagnosis of ADHD. This study was a 
triple-blinded prospective study. 275 children and adolescents with attention and 
behavioral problems were evaluated at 13 sites. Each of these sites had a qualified 
clinician who completed differential diagnosis evaluations. A separate multidisciplinary 
team comprising a psychiatrist, psychologist, and neurodevelopmental pediatrician 
completed an independent consensus evaluation. Finally, separate teams collected EEG 
data at each site. Clinicians identified 209/275 subjects as having ADHD. The 
multidisciplinary team identified 93 less. However, 85 of these 93 also exhibited EEG 
characteristics of ADHD (i.e., lower theta/beta ratio).  Overall, the results of the study 
indicated that the integration of EEG markers with clinical judgment could significantly 
improve diagnostic accuracy by 61 to 88%. 
Finally, an alternative qEEG methodology—wavelet synchronization—has been 
proposed as a new approach to diagnosing ADHD using EEG (Ahmadlou & Adeli, 
2010). In this study, the authors used nonlinear modeling to identify functional 
connectivity deficits in a sample of children ages 7-12 (n = 47 ADHD, n = 7 control). 
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Similar to the results of the fMRI studies described above, this suggests that the 
distinction between ADHD and non-ADHD populations extends beyond structural 
differences and into differences in function, specifically in terms of brain connectivity. 
Specifically, the results of the study indicated that O2 and P4 theta, as well as T5 delta 
exhibited significant differences in connectivity between the groups, suggesting deficits 
in visual and auditory processing as well as data integration. This is consistent with the 
results of a 2012 study (Ahmadlou & Adeli, & Adeli, 2012) in which the authors found 
that differences in left-hemisphere connectivity, within the delta range, could differentiate 
between ADHD and non-ADHD individuals. This methodology has also been used in the 
diagnosis of epilepsy and seizure disorders (Faust, Acharya, Adeli, & Adeli, 2015) 
demonstrating again that qEEG is a useful diagnostic tool for a number of neurologically-
based psychological disorders, which are summarized in Table 1.1. 
QEEG as Treatment for ADHD 
One of the greatest benefits of qEEG is that it provides not only a means of 
identifying disorders but it can also be extended for use in treatment. One area of 
research, neurofeedback (NF), does just that. In fact, NF has shown great promise in 
treating neurodevelopmental conditions, because it purportedly directly impacts brain 
functioning. Some researchers claim it is based on the scientific foundation of operant 
learning, where behavior is increased or decreased based on the consequences of 
behavior (e.g., Sterman, 2000, Thatcher, 2000) while others claim it is a form of self-
regulation training (e.g., Decker, Roberts, & Green, 2014; Johnston, et al., 2010). 
Regardless of the theoretical underpinnings to which one subscribes., NF uses 
electroencephalography (EEG) to monitor cortical activity by placing small electrodes on 
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the scalp, via a fabric cap, or geodesic net. These electrodes detect very small electrical 
currents that are then amplified and recorded with the use of a computer. Like other 
forms of biofeedback, the subject is then provided with feedback (i.e., visual and/or 
auditory stimuli) contingent upon the brain activity detected. Low-resolution brain 
electromagnetic tomography (LORETA) is a more advanced form of NF that extends 
surface EEG NF. It works by using data from 19 (or more) electrodes to localize cortical 
and subcortical current densities.  
For example, the dorsal and ventral attention networks, as well as the default 
mode network (Janssen et al., 2015; McCarthy, et al., 2014), have been implicated in 
ADHD. Each of these networks involves multiple areas of the brain. For example, the 
dorsal attention network includes the intraparietal sulcus and frontal eye fields (i.e., 
Brodmann Area [BA] 8), whereas the ventral attention system is made up of the ventral 
frontal cortex (i.e., BA 44, 45, 47) and the temporoparietal junction (Vossel, Geng, & 
Fick, 2014). The Default Network, on the other hand, is a much more vast and diffuse 
network, which comprises Brodmann Areas 8, 9, 10, 21, 23, 24, 28, 29, 30, 31, 32, 36, 
39, and 40 (Buckner, et al., 2008; Thatcher, North, & Biver, 2014). Although these areas 
are oft associated with ADHD, research has demonstrated that other areas of the brain are 
also related to attentional difficulties (i.e., BA 10, 11, 22, 23, and 24; Gitelman et al., 
1999). In looking at all of the possible brain regions, which could be impacted by ADHD, 
it becomes increasing important to examine the needs of each individual. 
The use of LORETA enables the user to identify both dorsal (i.e., cortical) and 
ventral (i.e., subcortical) Brodmann areas that are exhibiting atypical patterns of 
activation, based on a normative sample, which allows for targeted and individualized 
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training protocols. One program, Neuroguide, compares individuals to a normative 
sample of 625 participants (ages birth – 82 years). The Neuroguide software (through 
which LORETA is available) also exports data on both raw EEG and Z-score metrics, 
such that areas of atypical activation (i.e., those with Z ≥ 2) can be trained towards 
typical activation (i.e. Z = 0). Overall, the power of LORETA to generate inferences 
about, and to train subcortical areas, has the potential to greatly extend the scope and 
efficacy of NF.  
Neurofeedback in Clinical Practice 
Neurofeedback is a biofeedback technique that facilitates self-awareness and 
behavioral control by making the electrical activity of a person’s brain activity observable 
on a computer screen. Although a relatively new technique, many research studies have 
supported the efficacy of NF for the treatment of children with neurodevelopmental 
disabilities in learning or attention (i.e., Arns, de Ridder, Strehl, Breteler, & Coenen, 
2009; Beauregard & Levesque, 2006; Breteler, Arns, Peters, Giepmans, & Verhoeven, 
2010; Gevensleben, Holl, Albrecht, Schlamp, Kratz, Studer, et al., 2010; Gevensleben, 
Holl, Albrecht, Vogel, Schlamp, Kratz, et al., 2009; Levesque, Beauregard, & Mensour, 
2006; Lofthouse, Arnold, Hersch, Hurt, & DeBeus, 2012; Logemann, et al., 2010; Lubar, 
Swartwood, Swartwood, & O’Donnell, 1995; Walker, 2010).  
For example, three recent studies have supported the use of NF for the treatment 
of ADHD in both children and adults. The first examined changes across three groups of 
children (ages 6-18) with ADHD (Duric, Assmus, Gundersen, & Elgen, 2012).  In this 
study, the authors compared three groups of children—those receiving NF only (n = 23), 
those receiving only methylphenidate (n = 29), and those receiving a combination of both 
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treatments (n = 24). The NF training in this study was operationalized as thirty 40-minute 
sessions, thrice weekly. The sessions consisted of 5 minutes of baseline (i.e., alpha 
training), followed by 30 minutes of beta/ theta NF training, and finally another 5-minute 
baseline at the end. Results indicated significant symptom reduction for all three 
treatment groups, based on parent report. Additionally, although significant differences 
were not found between the treatment groups, it is notable that the NF-only group 
exhibited more than twice the pre-test post-test change in attention. Overall, the authors 
concluded that NF treatment is as effective as methylphenidate treatment in the reduction 
of ADHD symptoms in children, based on parent-report.  
A second study examined the activation of the Default Mode Network (DMN) in 
12 children (age 9-15) with ADHD (Russell-Chapin, et al., 2013). All of the children 
were taking stimulant medication throughout the duration of the study, and participants 
were randomly assigned to receive NF treatment or no treatment [in addition to their 
medication regime]. The treatment group received 40 sessions of NF training over the 
course of 92 days. Results indicated that NF treatment resulted in both a reduction of 
clinical symptoms as a well as a consolidation (i.e., appropriate activation) of the DMN. 
The DMN was more consolidated in the treatment group than the control group, 
suggesting the NF treatment impacted the consolidation beyond what time alone would 
cause.  
A third study, examined the effects of NF treatment of a group of 18 children 
(Mage = 13.6 years) with ADHD (Hillard et al., 2013). In this study, 12 of the participants 
(66.67%) were taking stimulant medication throughout the duration of the study. 
Participants each completed 12 weekly sessions, consisting of 25 minutes of NF training 
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each, which consisted of a “Focus/Alertness" protocol through the program Peak 
Achievement Trainer®. ANOVA results indicated main effects both between (i.e. session 
1 to session 12) and within sessions (i.e., from minute 1 to minute 25). Specifically, the 
theta/low beta and theta/alpha ratios decreased significantly from pretest to posttest as 
well as from the start of a session to the end of that same session.  Additionally, these 
changes generalized to participant’s performance on commonly used behavioral measures 
(i.e., IVA+, Aberrant Behavior Checklist [ABC]) from pretest to posttest. Participants’ 
performance on the IVA+ indicated significant changes on 10 metrics, including both 
visual and auditory attention metrics. Finally, parent report on the ABC showed a 
significant decrease in behavior problems (e.g., hyperactivity) from pre-test (15.28 ± 
3.24) to post-test (10.83 ± 2.44); t(17) = 3.189, P = .005. 
On the other hand, there are have been some studies, which have not supported 
the efficacy of NF for the treatment of ADHD. One such study (Ogrim & Hestad, 2013) 
was a randomized pilot study of 32 medication-naïve children (ages 7-16) with ADHD. 
Sixteen children received 30 sessions of 45 minute NF training (over 7-11 months), and 
the other group received either methylphenidate or dextroamphetamine. Both behavioral 
data (i.e., parent/teacher rating scales) and EEG data was collected. The results of the 
study indicated that neither treatment exhibited significant changes in qEEG or ERP. 
Additionally based on parent/ teacher ratings, the medication group exhibited significant 
symptom reduction while the NF group did not.  
Similarly, Vollebregt and colleagues (2013) completed a double-blind placebo-
controlled study of 41 children (ages 8-15) with ADHD using individualized NF 
protocols. The results of this study indicated mixed results.  First, no group differences 
14 
were found on several neurocognitive measures (e.g., digit span, sustained visual 
attention). Second, although participants all demonstrated significant improvement on at 
least one metric, they all also demonstrated deterioration on at least one measure. As 
such, the study did not support the use of NF as a treatment for ADHD. 
Although there is some conflicting evidence, most studies generally support the 
use of neurofeedback in the treatment of ADHD. Furthermore, previous research has 
suggested that NF is effective for treating a variety of neuropsychiatric disorders, such as, 
anxiety disorders (Moradi, Pouladi, Pishva, Rezaei, Torshabi, & Mehrjerdi, 2011) 
including obsessive-compulsive disorder (Sürmeli, & Ertem, 2011); depression (Baehr, 
Rosenfeld, & Baehr, 2001; Choi, Chi, Chung, Kim, Ahn, & Kim, 2011); autism 
(Jarusiewicz, 2002; Kouijzer, de Moor, Gerrits, Buitelaar, & van Schie, 2009); and 
schizophrenia (Sürmeli, Ertem, Eralp, & Kos, 2011). However, many of the previously 
published studies have methodological limitations that prevent a clear understanding of 
the efficacy of the technique (Loo & Barkley, 2005). More recently, Meisel and 
colleagues (2013) completed a randomized control trial comparing the long-term effects 
of NF versus stimulant medication. The study included 23 children who were randomly 
assigned to either a methylphenidate pharmacological intervention, or 40 sessions of NF, 
twice per week for approximately 35-minute sessions. Data was collected at pre-test and 
post-test, as well as a 3-month and 6-month follow-up after completion of the study. 
Results suggested that the NF group exhibited a significant reduction in symptoms (i.e., 
hyperactivity, impulsivity, inattention), a significant reduction in functional impairment, 
and a significant improvement in academic performance (i.e., writing, math), at the 3- 
and 6-month follow-ups. Additionally, this group exhibited and a significant 
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improvement in oppositional defiant (OD) behaviors at the 3–month follow-up, though 
not at 6 months post-treatment. The methylphenidate group exhibited similar core 
symptom reduction at 3- and 6-month follow-ups in addition to a reduction in functional 
impairment and OD symptoms at 6-months. In directly comparing the two groups, the 
authors found no significant differences between the groups; however, the results were 
confounded as many of the NF group participants (N = 8) began a medication regime 
prior to the 6-month follow-up. This suggests that in spite of the vast improvements in 
recent years, there is still a great deal of research needed in this area. 
LORETA Neurofeedback 
Several studies have examined more sophisticated approaches to using NF. One 
approach is LORETA, which can provide more localized targeting of brain regions in 
comparison to surface EEG. One study found that LORETA NF appeared to strengthen 
connectivity, and improve functioning in a nonclinical population (Cannon, et al., 2009). 
Another study, examined the utility of LORETA NF with an ADHD population 
(Koberda, et al., 2014). This study, an in-depth case study, demonstrated the impact of 
LORETA NF on both qEEG (i.e., reduction of excessive beta) and behavioral data (i.e., 
computerized neurocognitive assessment) metrics.  
However, few NF studies using LORETA under randomized control conditions 
have been completed, and none to date have used a delayed treatment design. A delayed 
treatment design can provide stronger evidence in support of the effectiveness of a given 
intervention if both groups demonstrate change in the expected direction. Additionally, a 
delayed treatment design is often considered more ethical than a waitlist design, 
particularly when an effective treatment is being withheld. In fact, because of the great 
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potential of NF as a therapeutic option, in 2011, the American Academy of Pediatrics 
(AAP) listed NF as promising but in need of more research. However, in 2012, the AAP 
elevated NF to a “Level 1-Best Support” for intervention for attention and hyperactivity 
behaviors. Each year the AAP releases a report of evidence-based interventions (EBIs) 
for a variety of disorders in childhood and adolescence. The level designations were 
adapted from the American Psychological Association’s (APA) Task Force on Promotion 
and Dissemination of Psychological Procedures. A Level-1 designation means that a 
given intervention has shown efficacy in at least two randomized trials by at least two 
different research teams.  
Although NF has been recently gaining support as an empirically based 
intervention, more research is needed, particularly in terms of LORETA NF.  Previous 
research (i.e., that reviewed by the American Academy of Pediatrics) has focused on 
surface NF, which has been demonstrated to be effective after several sessions (i.e., 60 
sessions; Koberda, et al. 2014).  
The current study, on the other hand, was one of the first investigations of 
LORETA neurofeedback using a randomized control research design with a placebo (or 
sham) condition for the treatment of learning and attention problems. As described above, 
LORETA neurofeedback is a more sophisticated NF technique intended to generate 
inferences about sub-cortical structures, with the goal of training these areas. It is notable 
that while LORETA can target subcortical structures, it is still largely based on 
Brodmann areas, which are by definition, cortical regions. However, by targeting these 
subcortical structures, it should allow for more targeted, and thus faster and/or more 
effective results (Simkin, Thatcher, & Lubar, 2014; Wigton & Krigbaum, 2014).  
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The Current Study 
The current study aimed to overcome the methodological limitations of past 
research (see Loo & Barkley, 2005), and to extend this research with a delayed treatment 
design in order to provide a better understanding of the effectiveness of LORETA NF. 
Specifically, the delayed treatment design provided a unique opportunity to evaluate the 
dose-response rate of NF LORETA NF. Previous research suggests 20-50 sessions are 
needed to demonstrate change (Arns et al., 2009; Holtmann, et al., 2009, Holtmann, et al., 
2014). LORETA NF may produce results in less time because it enables the clinician to 
target select areas of impairment, which are consistent with a specific set of symptoms 
and related brain regions (Simkin, Thatcher, & Lubar, 2014). Furthermore, with its focus 
on ADHD in college students, the study will contribute to the literature on the disorder 
with this population. 
The major objective of this study was to test the effects of individualized 
LORETA NF in college students who experience difficulties as a result of ADHD. This 
was evaluated through three specific aims: 
1. To test the hypothesis that LORETA NF can change brain activity in a sample of 
college students with ADHD. 
2. To test the hypothesis that changes in brain wave activity as a result of LORETA 
NF, correspond to changes on behavioral tests of cognitive abilities (i.e., WJ-III 
and CPT subtests);. 
3. To test the hypothesis that LORETA NF demonstrates faster changes than 
traditional surface NF (i.e., changes occur prior to 20 sessions). 
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These specific aims were then assessed according to the following hypotheses, which are 
summarized in Figure 1.1: 
 Treatment vs. Sham (sessions 1, 10, 25) 
o Hypothesis 1: Students in both conditions will show equivalent 
impairment at pretest as measured by behavioral measures of cognitive 
ability and baseline qEEG; 
o Hypothesis 2: Students in the NF condition will demonstrate greater 
change toward normality than students in the sham condition at session 10, 
as measured by: 
a) Greater qEEG change toward normality (i.e., Z = 0); 
b) Better performance on widely used behavioral measures of 
cognitive ability; 
o Hypothesis 3: Students in the sham condition, after session 10, will begin 
to demonstrate changes in brain activity and cognitive performance similar 
to that of students in the NF condition at session 25, as measured by: 
a) Both groups exhibit qEEG change toward normality (i.e., Z = 
0); 
b) Both groups exhibit improved performance on widely used 
behavioral measures of cognitive ability; 
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 Dose-Response Relationship (sessions 15, 20, 25) 
o Hypothesis 4: Students in NF condition will demonstrate a continual 
pattern of change toward normality from sessions 15 to 25, as compared to 








Table 1.1 Studies in which EEG/qEEG metrics linked to diagnosis of other disorders 
 
 
Disorder Studies  
Alzheimer’s Disease   Adeli, Ghosh-Dastidar, & Dadmehr (2008) 
 Gawel, Zalewska, Szmidt-Sałkowska, & Kowalsi (2009) 
 Herrmann & Demiralp (2005) 
Antisocial Personality Disorder  Calzada-Reyes, Alvarez-Amador, Galán-García, Valdés-Sosa (2012) 
Autism  Ahmadlou & Adeli (2014) 
 Cantor & Chabot (2009) 
 Sheikhani, Behnam, Mohammadi, Noroozian, & Mohammadi (2012) 
Epilepsy/ Seizure Disorders  Leach, Stephen, Salveta & Brodie (2006)  
 McGonigal, Oto, Russell, Greene & Duncan (2002) 
 Croona, Kihlgren, Lundberg, Eeg-Olofsson & Edebol- Eeg-Olofsson (1999) 
 Faust, Acharya, Adeli, & Adeli (2015) 
 Mormann, Lehnertz, David & Elger (2000) 
Learning Disabilities  Cantor & Chabot (2009) 
 Rocha, Massad, Thomaz, & da Rocha (2014) 
Mood Disorders   Begić, et al. (2011) 
 Koek, et al. (1999) 
Schizophrenia   Boutros, et al. (2008) 
 Knyazeva, et al. (2008) 
Traumatic Brain Injury  Bozorg et al. (2010) 
 Duff (2004) 
 Roberts, Englund, & Scherr (2011) 
 Ronne-Engstrom & Winkler (2006) 
 Thatcher et al. (2001) 















Figure 1.1 Study Hypotheses. This figure illustrates the four study hypotheses. Red = hypothesis 1  
(equivalence at pretest), green = hypothesis 2 (group differences at session 10), blue = hypothesis 3  
































Participants for this study included 16 college undergraduates who were 
documented as having a diagnosis of ADHD. Participants were recruited through the 
university’s participant pool, flyers posted around campus, newspaper advertising, and 
word-of-mouth.  Each participant was randomly assigned to a treatment condition. Eight 
participants were randomly assigned to the sham (placebo) condition and eight 
participants were randomly assigned to the neurofeedback (NF) treatment condition. 
Participants received course credit for the initial screening process, and $125 for the 
completion of the sessions. 
Inclusion/ exclusion criteria. In order to qualify for the study, participants were 
required to complete screening questionnaires documenting their diagnosis of ADHD. 
These included questions regarding the age at which they were diagnosed, the type of 
professional that made the diagnosis, possible comorbid conditions, and self-reported 
symptoms, as well as providing documentation regarding any stimulant medication they 
were currently prescribed. Additionally, they completed a baseline QEEG, and using the 
Neuroguide symptoms checklist, it was determined if there were matches between 
reported symptoms and QEEG abnormalities. Only those students who exhibited QEEG 





during the academic year, it was not practical to ask students to discontinue their current 
treatment plan; however, an attempt was made to covary medication status.  
Participant attrition. The use of college students allowed for easy access to 
follow-up with participants as well as to replace them as the need arose. Additionally, 
participants received course credit (or extra credit) for participation in research as well as
remuneration in the hopes of retaining as many participants as possible. Using a college 
population and having multiple sources of compensation greatly increased the potential to 
successfully recruit participants and to complete the study within a reasonable time 
frame.  However, twenty-six participants were enrolled in the study, of which 10 were 
replaced due to time constraints, personal matters, and/or poor attendance to reach the 
projected 16 participants. 
Measures 
Screening. Participants completed an online screener in order to determine initial 
eligibility. This screener included demographic information, questions regarding their 
diagnosis, and questions about past and current symptomatology. Demographic questions 
were included in order to assess pre-test group equivalency, and to evaluate possible 
covariates in later analyses. Participants were asked if they have a documented diagnosis 
of ADHD, which was confirmed by other assessments measuring symptom severity. 
Symptom severity. In order to assess symptomatology, two published measures 
were adapted for use online. The first was Barkley’s Current Symptoms Scale—Self-
Report Form (BCSS; Barkley & Murphy, 2006), which provides a measure of self-
reported ADHD symptoms. This scale has 36 items, which represent DSM-IV-TR 





of inattention and hyperactivity/impulsivity. The remaining 18 items assess settings of 
impairment, and comorbid symptoms of oppositional defiant disorder. Individuals were 
asked to respond on a Likert-type frequency scale, ranging from 0 (never/rarely) to 3 
(very often). 
Although psychometric evidence for the BCSS is reported infrequently, there 
have been a few studies to validate the measure with adults. For instance, the scale has 
been demonstrated to discriminate moderately well between ADHD and non-ADHD 
populations. Quinn (2003) found that the inattention symptoms had 75% sensitivity, and 
61% specificity, while the hyperactivity/impulsivity symptoms had 69% sensitivity and 
39% specificity. While these estimates are lower than desirable, it prompted additional 
research into the psychometric properties of the BCSS. Most recently, Ladner, 
Schulenberg, Smith, and Dunaway (2011) examined the reliability and validity of the 
scale with more than 600 university students. Ladner and colleagues reported moderately 
high internal consistency coefficients for both inattention (Cronbach’s  = .88) and 
hyperactivity/impulsivity (Cronbach’s  = .82). Additionally, Cronbach’s  = .91 for the 
entire scale. The study also investigated concurrent validity of the BCSS with the 
Conner’s Adult ADHD Rating Scales-Self Report Long Form, and the Adult Attention 
Deficit Disorders Evaluation Scale.  Results indicated that the BCSS correlated 
moderately to highly (r = .58 - .87) with both of these measures. Although ideally, 
measures would demonstrate consistently higher reliability and validity coefficients (i.e., 






The second scale, the Barrett Impulsiveness Scale (BIS; Patton, Stanford, & 
Barratt, 1995), is a 30 item, self-report measure, which provides an assessment of 
impulsivity. Now in its eleventh edition, the BIS has been used extensively in research 
and clinical practice for more than 50 years, and is arguably the gold standard for 
measuring symptoms of impulsivity (Malloy-Diniz, Fuentes, Leite, Correa, & Bechara, 
2007; Stanford, Mathias, Dougherty, Lake, Anderson, & Patton, 2009). Factor analyses 
of the current edition of the BIS, identified six sub-traits of impulsivity—attention, 
cognitive complexity, cognitive instability, motor, perseverance, and self-control—that 
are subsumed under the three second order factors of attention, motor, and non-planning. 
Impulsivity is a symptom of ADHD, and as such was of relevance to the current study, 
particularly as the population of interest is college students. To complete the scale, 
individuals were asked to respond on a Likert-type frequency scale ranging from 1 
(never/rarely) to 4 (almost always/always).  
Stanford et al. (2009) provide the most recent and comprehensive evaluation of 
the psychometric properties of the BIS-11. In fact, the study included measures of 
reliability and validity for total scores, as well as for each of the first and second order 
factors. Internal consistency (Cronbach’s  = .83) and test retest reliability (Spearman’s 
Rho = .83) were acceptable for the entire scale; however, the reliability estimates were 
lower for the individual factors (Cronbach’s  = .27 - .74, Spearman’s Rho = .23 - .74). 
Intercorrelations among the subscales were also reported, ranging from r = .16 - .91. In 
addition to reliability, the authors evaluated the concurrent validity of the measure with 
four other impulsivity scales (e.g., Zuckerman Sensation Seeking Scale, Eysenck 





of Impulsiveness). The BIS-11 significantly correlated (r = .10 - .63) with all but the last 
of these, though that study included a solely non-clinical population. 
These measures were used to confirm diagnosis and to assess symptom severity, 
not to determine inclusion for the study. As neither of these measures were intended for 
diagnostic purposes, a cut-score was not used. Instead, scores were used on a continuum 
to indicate symptom severity for both groups. The original demographic survey and 
copies of both screening measures are included in Appendix B. 
Outcome measures. 
Quantitative electroencephalography. EEG and qEEG have demonstrated a high 
degree of both reliability and validity in the medical field, and more recently in 
psychology. There are several types of measurements within the context of qEEG, though 
only absolute power and coherence will be analyzed in this study. Absolute power refers 
to the amount of voltage recorded within each band (i.e., delta, theta, alpha, beta, 
gamma), and has been extensively researched, and demonstrated to be highly reliable 
(i.e., r ≥.9) for both split-half and test- retest reliability (Thatcher, 2010). Coherence on 
the other hand, refers to the communication between brain regions. Coherence has also 
been shown to be reliable (r ≥.8) across several studies (i.e., Corsi-Cabrera, Solís-Ortiz, 
Guevara, 1997; Corsi-Cabrera, Galindo-Vilchis, del-Río-Portilla, Arce, & Ramos-Loyo, 
2007; Thatcher et al.,1986) with some studies reporting reliability coefficients as high as 
r = .95 (Fernández, Harmony, Rodríguez, Reyes, Marosi, & Bernal, 1993; Corsi-Cabrera 
et al., 2007). With regards to validity, less research has examined absolute power or 
coherence alone, but qEEG has been shown to have high sensitivity (as high as 96%) for 





Additionally, in 2001, Thatcher and colleagues also developed a discriminant function to 
classify traumatic brain injury patients based on symptom severity, which was validated 
based on its consistency with emergency department admission measures (e.g., Glasgow 
Coma Scale) and post-trauma neuropsychological testing results. For an in-depth review 
of the reliability, clinical utility, and validity literature, see Roberts (2012). 
Working memory. Cognitive deficits, specifically in working memory, are 
common in individuals with ADHD (Alderson, Rapport, Hudec, Sarver, & Kofler, 2010; 
Kofler, Rapport, Bolden, Sarver, & Raiker, 2010; Martinussen, Hayden, Higg-Johnson, & 
Tannock, 2005; Rapport, Bolden, Kofler, Sarver, Raiker, & Alderson, 2009). As such, 
this study included three measures of short-term/ working memory. This study used the 
Woodcock-Johnson Tests of Cognitive Abilities, Third Edition (WJ III COG). The 
Woodcock-Johnson Tests are held in high esteem due to their performance in various 
reliability and validity analyses that have been conducted, both by the test developers and 
external researchers. For instance, the core subtests have median reliability coefficients of 
r11 = .81 - .94 (McGrew, Schrank, & Woodcock, 2007).  Additionally, according to 
Flanagan, Ortiz, & Alfonso (2007), the WJ tests are the most comprehensive of the 
mainstream intelligence batteries, because they include measures of all of the Cattell-
Horn-Carroll (CHC) broad abilities. Furthermore, the WJ III COG has been shown to 
produce reliable and valid results across a variety of ages and cultures (Edwards & 
Oakland, 2006; McGrew, Schrank, & Woodcock, 2007, Taub & McGrew, 2004).  
As the construct of interest is working memory (Gsm), only scores from the 
numbers reversed, memory for words, and auditory working memory subtests were used. 





reversed, r11= .87, memory for words, r11 = .80, and auditory working memory, r11 = .87. 
Furthermore, the authors provide reliabilities for these subtests for individuals’ ages 18, 
(r11 = .87, .74, .86) 19 (r11 = .86, .80, .88), and 20 – 29 (r11 = .87, .78, .80) respectively. 
Additional information regarding the psychometric properties of the WJ III COG (i.e., 
intercorrelations, content and construct validity, and validity studies for specific 
subpopulations) is available in the Technical Manual (McGrew, Schrank, & Woodcock, 
2007).  
Attention. Another core executive function deficit associated with ADHD is 
sustained attention (Christakou, Murphy, Chantiluke, Cubillo, Smith, Giampietro, et al., 
2012; Tillman, Bohlin, Sorensen, & Lundervold 2009). As such, a computerized 
sustained attention task was administered. The Conners’ Continuous Performance Test, 
Second Edition (CPT-II) is one of the most widely used continuous performance 
assessments available. The administration of this test takes approximately 15 minutes, 
during which individuals were asked to discriminate between stimuli presented on the 
screen. Individuals were instructed to press the space bar when presented with target 
stimuli, and to suppress this behavior when a non-target stimulus was presented. The test 
provides a number of performance measures (i.e., reaction time, omission errors, 
commission errors), each of which have been independently evaluated for reliability and 
validity.  
Psychometric data from the original standardization sample is provided in the 
Technical Manual (Conners, 2000). Split-half reliabilities for the three most commonly 
used metrics (i.e., reaction time, omission errors, commission errors) were r = .95, r = 





.84), though still acceptable for many metrics. The author also conducted discriminant 
validity studies prior to initial publication, and found that the CPT significantly 
discriminated between ADHD, neurologically impaired, and non-clinical populations on 
all metrics. Finally, the manual reports the precision of the CPT in classifying ADHD 
versus non-clinical adults (sensitivity = 82%, specificity = 83%).  
Equipment 
Hewlett Packard laptops were used during data collection and analysis. Additional 
Dell desktop computers were used during the data analysis phase as well. The Brain 
Master Discovery 24E amplifier (Brainmaster Technologies, Inc., Bedford, OH; 
Discovery version 3.4) was used to record raw EEG data. The Brain Master Discovery 
24E amplifier was selected as a result of its compatibility with Neuroguide (Applied 
Neuroscience, Inc., Largo, FL), which was used to collect the raw EEG data and to 
produce the quantitative EEGs (qEEG). Indeed, this amplifier has been used in a number 
of similar studies in conjunction with Neuroguide (i.e., Donaldson, et al., 2012; 
Luangboriboon, Tantayanon, & Wongsawat, 2013), and this combination of software was 
recommended  in a recent textbook chapter entitled Optimal Procedures in Z-Score 
Neurofeedback (Lubar, 2014). 
As described in Wigton & Krigbaum (2015), the Brain Master Discovery 24E 
amplifier has an EEG bandwidth of .43 to 80 Hz, and an A/D conversion of 24 bits. 
Additionally, while the amplifier has the capacity to sample at 1024 samples per second, 
the data rate to the computer is much slower (i.e., 256 samples per second). Furthermore, 
as described in Wigton & Krigbaum (2015), the Neuroguide acquisition module employs 





other electronic devices in the laboratory (e.g., other computers, cell phones, building 
generators).  
MATLAB 2007b (Mathworks, Inc.), Microsoft Office 2013, R (The R Foundation 
for Statistical Computing, 2004-2013), and IBM SPSS Statistics v. 22 were used for final 
data organization and analysis.  
Research Design 
This study employed a pre-test, multiple post-test, delayed treatment design with 
random assignment. The subjects were randomly assigned to one of two groups—a 
treatment and sham condition. At baseline, subjects completed a quantitative EEG 
(qEEG) in addition to a number of psychoeducational measures. These measures were 
completed again halfway through the study to examine whether the treatment group was 
making progress above that of the sham group. At the mid-point, the sham group began 
receiving the treatment series in order to provide a secondary assessment of the treatment. 
Both groups then completed post-test measures at the end of the study as well to again 
examine group differences. 
Neurofeedback condition. Participants in the randomly assigned NF condition 
received LORETA Z score biofeedback of the default mode and attention networks 
following the first administration of the cognitive battery and the EEG baseline data 
collection. The baseline QEEG was used to identify Brodmann areas at a Z ≥ 2.0 entry 
criteria that were consistent with a diagnosis of ADHD. In order to target both the default 
mode and attention networks within the constraints of the software, two symptoms were 
selected for all participants—attention difficulties and executive function deficits. This 





mode network and the attention networks.  Table 2.1 provides a list of the 24 possible 
Brodmann areas across hemispheres, and Table 2.2 provides a list of the matches by 
participant. Participants were asked to return to the lab to complete 25 LORETA Z score 
biofeedback sessions (each consisting of 20 minutes active training) over the course of 
the academic year. This number of sessions was selected based on the literature, 
suggesting that 20-50 sessions are needed for maintenance of the change (i.e., Fuchs et 
al., 2003). The goal of these sessions was to target the identified Brodmann areas. These 
Brodmann areas were then measured in real-time and the Z-tunes setting was used to 
train the selected brain regions toward Z = 0.  Through Neuroguide, there are three 
options for Z-score neurofeedback training. These setting options include all-or-nothing, 
where the individual only receives feedback when 100% of the areas being trained meet 
the Z-score criteria during a set time period (i.e., window), average, where the average Z-
score [computed across all areas trained] must meet the Z-score criteria to be rewarded, 
and Z-tunes, which is what was used in this study. The Z-tunes option is the default, and 
thus preferred, setting because it is a Gaussian Adaptive filter. This approach begins as 
all-or-nothing and adapts based on the individual’s performance in order to prevent the 
reinforcement of extreme (i.e., outlier) scores. The feedback criterion was set to achieve 
> 60% rewards and adjusted toward smaller values as the subject progressed over 
sessions. The 60% threshold was based on the suggestion of Dr. Robert Thatcher, who 
created the Neuroguide software. The feedback signal was a multimedia display (i.e., a 
colored dot plus music) that faded when Z scores failed to meet criteria and played when 





Sham control condition. Participants in this condition received a Sham (control) 
condition over the first 10 sessions. For this control, electrodes were attached and 
connected to the amplifier but the “playback” option was selected so that there was no 
relation between the NF EEG and the subject’s EEG.  Sham participants received 
feedback in the form of randomly selected baseline qEEGs from the other participants, 
rather than randomly generated noise, to better simulate feedback, and to ensure the 
single-blind nature of the study. After the first 10 sessions, they began to receive 
contingent feedback to see if they too began to show a learning curve and/or behavioral 
changes.   
Procedure 
Participants completed an online pre-screener providing demographic information 
and symptom severity. At the initial session, participants completed informed consent, 
and were given an opportunity to ask questions. They were administered the behavioral 
pretest measures (WJ subtests and CPT), which were counter-balanced to account for 
possible order effects. Participants were then fitted with a standard 19-channel Electro-
Cap, which uses the international 10-20 system for electrode placement. Impedance was 
kept at or below 10KΩ for each of the electrodes, and below 5KΩ for most participants. 
Additionally, ground leads were placed on participants’ ears, and impedance was kept at 
or below 5KΩ. Baseline recordings were taken for three minutes each while the 
participants’ eyes were open and closed. If participants’ baseline EEG recordings showed 
atypicalities consistent with ADHD (i.e., exhibited matches on the Symptoms Checklist), 
they were given the option to begin their first session of NF.  Another eyes open baseline 





At the start of each subsequent session, a baseline recording was taken for three 
minutes while the participants’ eyes were open. Participants then completed four, five-
minute sessions of (real or sham) neurofeedback, followed by a three-minute eyes open 
baseline. At the end of each session, participants were also asked to complete a brief 
subjective change index, indicating if they noticed changes in a number of areas (e.g., 
positive/ negative emotions, learning, attention, language) since beginning the study. 
After the 10th session, participants in the sham condition began receiving real NF, until 
the end of the study. At the tenth and final (25th) sessions, participants completed the 
post-test behavioral measures in addition to their 20 minutes of active treatment and EEG 
eyes-open baselines. An additional eyes-closed baseline was collected at the end of these 






Table 2.1. Possible Symptom Checklist Matches 
 
 
Brodmann Area Brain Region 
7 Parietal 
8 Frontal 
9 Dorsolateral Prefrontal Cortex 
10 Prefrontal  
11 Prefrontal  
19 Occipital 
23 Cingulate 
24 Anterior Cingulate 
33 Anterior Cingulate 
45 Dorsolateral Prefrontal Cortex 
46 Frontal 
47 Frontal 






Table 2.2. Symptom Checklist Matches by Participant 
 
 
Subject BA Areas Bands Total Metrics 
NF_005 8, 9, 24 L, 47L D 21 
NF_006 10R, 11R, 47R D, T 9 
NF_007 7, 8, 9, 19R, 23, 24, 33, 45R, 46R T, A, A1, A2, B1, B2 104 
NF_008 7, 8, 9, 10L, 11, 19, 23, 24, 45, 46, 47L A, A1, A2, B1, B2 123 
NF_009 8R, 9R, 10R, 11, 19R, 45R, 46R, 47R D, T, A, A1, A2, B1, B2 128 
NF_010 7, 8, 9, 10, 11, 19, 23, 24, 33, 45, 46, 47 D, T, A, A1, A2, B1 193 
NF_011 8R, 9, 10, 11, 19, 24, 45R, 46, 47 D, T, A, A1, A2, B1, B2 146 
NF_012 10R, 11R, 47R D 6 
NF_013 10, 11, 46R, 47R D 21 
NF_016 8 R, 9 R, 10, 11, 45R, 46, 47 D, T, B1 51 
NF_019 7, 10 L, 11, 19, 23, 45L, 47L D, T, B1, B2 46 
NF_020 7, 8 L, 9 L, 19 T, A, A2 16 
NF_023 7, 8, 9, 10, 11, 19, 23, 24, 33, 45, 46, 47 D, T, A, A1, A2 196 
NF_024 7 R, 8, 9, 10, 11, 19, 23, 24, 33, 45, 46, 47 A, A2, B1, B2 91 
NF_025 7 R, 8, 9, 10, 11, 19R, 24, 33, 45, 46, 47 D, T, B1, B2 116 
NF_026 8, 9 L, 23, 24, 33,  A, A2 66 







QEEG Data Selection 
 Prior to conducting statistical analyses, previous research was consulted in 
order to complete more targeted analyses, and to preclude the need to correct for multiple 
comparisons. Prior research indicates that the prefrontal cortex (PFC) and inferior frontal 
gyrus (IFG) exhibit significant differences between ADHD and non-ADHD individuals 
(i.e., Friedman & Rapoport, 2015; Janssen, et al., 2015; Valera, et al., 2007). Similarly, 
the participants in this study exhibited atypical patterns of behavior in those areas. 
Specifically, all 16 participants received training in the PFC, and 14/16 participants 
received training in the IFG. As such, qEEG analyses were focused on these two areas.  
 Furthermore, the LORETA NF training was targeted via Brodmann Areas; 
however, the data was collected in reference to 19 electrode channels. As such, these 
regions of interest were related back to the electrode metric for ease of analysis based on 
previous research (Okamoto, et al., 2004; Thompson, Thompson, & Wenqing; 2013). The 
following electrodes were selected to account for the designated Brodmann Areas: PFC, 
including the dorsolateral prefrontal cortex and orbitofrontal cortex (i.e., BA 8, 9, 10) = 
FP1, FP2, F3, F4, Fz, and IFG (i.e., BA 45, 47) = F7 and F8. 
QEEG Analyses  
Prior to running analyses, all EEG data was visually inspected to select a 





was taken to select data in two-second epochs whenever possible. This allowed for the 
use of the drowsiness and eye movement rejection options in Neuroguide, which helped 
to eliminate artifact from the data that followed recognizable patterns due to eye 
movement and/or drowsiness. Additionally, the automatic selection function was 
employed, which used the ten seconds of selected data as a model to automatically select 
similar data within the sample. This was done to ensure a minimum of 30-seconds of 
artifact-free data for each session. Next, power and coherence metrics were calculated via 
a fast-Fourier transformation. Neuroguide provided both raw scores and Z-scores (see 
Thatcher, 2011) for each. However, given that Neuroguide outputs tab-delimited-text 
(.tdt.) files, a simple Visual Basic Script was then used to transform these data files into 
Excel (.xls) files for ease of use. The data was then aggregated across subjects and 
sessions through MATLAB 2007b (Mathworks, Inc., 2007) and exported to Microsoft 
Excel, SPSS, and R (The R Foundation for Statistical Computing, 2004-2013) for final 
data analysis.  
 Group equivalency was evaluated at pretest through the use of independent 
samples t-tests on the LORETA absolute current density measures. Specifically, absolute 
power and coherence were examined. To minimize error due to individual differences, 
particularly those due to changes in brain development in young adulthood, the Z-score 
measures were selected for analysis. Additionally, given that the purpose of the study was 
to train atypical patterns of connectivity toward Z = 0, the Z-score metric was deemed the 
most appropriate.  
 To examine group differences across time, discriminant function analyses 





time points: at pretest, and following the completion of sessions 10, and 25. Additional 
discriminant function analyses were run to further investigate the findings, and to 
examine the dose-response relationship of LORETA NF. 
Behavioral Data A Priori Power Analyses 
 Due to the small sample size, a priori power analyses were run through 
G*Power (Faul, et al., 2007; 2009) in order to determine the likelihood of finding 
significant ANOVA results. For the CPT, moderate to large effect sizes were used to 
estimate power, given that previous studies have found similarly high effects of 
neurofeedback on symptoms of inattention and impulsivity (i.e., Partial η2 = .11 – .27) on 
similar tests (i.e., TOVA, IVA; Fuchs et al., 2003; Arns et al., 2009). The estimated effect 
sizes for the WJ subtests ranged from small (η2= .0099) to large (η2 = .2), as previous 
research into the efficacy of neurofeedback has tended to focus on measures of EEG (i.e., 
theta-beta ratios; Gevensleben et al., 2009), or ADHD symptomatology as measured by 
self, parent, or teacher report (e.g., BASC, Conners; Fuchs et al, 2003; Gevensleben et 
al., 2009) or continuous performance tasks (e.g., IVA, TOVA; Arns et al., 2009; Lubar et 
al., 1995). Additionally, previous studies that have examined changes in cognitive 
abilities, as measured by standardized measures such as the Wechsler or Woodcock 
Johnson Tests, have focused on full scale IQ, verbal/ perceptual abilities, or speed of 
processing, rather than on specifically measuring working memory performance. For all 
of the a priori analyses, alpha was set to .05, and the correlation among the repeated 
measures was set to .87, .80, and .87 and .55, .65, and .84 for the WJ III subtests and CPT 





in the technical manuals for the measures. Results of the power analyses are provided in 
the Table 3.1. 
 Given that previous research has suggested that neurofeedback has large 
effects on continuous performance tasks, it was anticipated that this study had sufficient 
power to detect similar effects. As previous research has not yet demonstrated the effects 
of NF training on the WJ measures of working memory, a range of effect sizes and power 
estimates were generated. As such, with such a small sample size, it was unlikely that 
small effects (η2 = .01) would be detected; however, moderate (η2 = .06) to large (η2 ≥ 
.14) effects should have been sufficiently powered. 
Behavioral Data Analyses 
 Prior to conducting analyses, the data were examined for adherence to 
distributional assumptions. Additionally, the two groups were assessed for pre-treatment 
equivalence using an independent samples t-test. 
 The behavioral analyses for this project were two fold—focusing on the 
between group differences on the short-term/working memory measures (i.e., WJ III) as 
well as on CPT performance. As such, correlations were run to determine the need for 
univariate or multivariate analyses. Correlations were also run to see if a relationship 
existed between the total number of areas trained or time to completion, and performance 
on the behavioral measures across time. A factor analysis was also conducted to further 
examine the relationship amongst the working memory measures.  
 Next, in order to use a repeated measures multivariate analysis of variance 
(RM-MANOVA), several other assumptions were tested. One of the first assumptions 





number of variables (p = 6) to be tested, which was met. However, in considering the 
data across the three time points, p = 18, and thus, the WJ and CPT analyses could not be 
run simultaneously. Furthermore, in testing some of the other assumptions, it became 
clear that multivariate analyses were not necessary for the CPT data, as the variables 
were not significantly related across time. As such, a repeated measures Multivariate 
Analysis of Variance (RM-MANOVA) was run for the WJ III subtests, and repeated 
measures Analyses of Variance (RM-ANOVAs) were run for each of the CPT measures 
separately. However, given that number of omission errors violated the assumption of 
homogeneity of variance at pretest, a nonparametric analysis was conducted to examine 
group differences on that CPT measure. Finally, post-hoc contrasts were run for measures 
approaching significance in the RM-ANOVA, in order to further examine the effect of 






Table 3.1.  A Priori Power Analyses 
 
 
 Partial η2 (Cohen’s d) 












WJ-III numbers reversed  
(r = .87) 
.35 .91 1.00 1.00 1.00  
WJ-III memory for words  
(r = .80) 
.24 .75 .98 
 
1.00 1.00  
WJ-III auditory working 
memory (r = .87) 
.35 .91 .1.00 1.00 1.00  
CPT omission errors  
(r = .55) 
- - .53 .78 .92 .98 
CPT commission errors  
(r = .65) 
- - .85 .98 1.00 1.00 
CPT Hit RT (r = .84) - - 1.00 1.00 1.00 1.00 








 Correlations were run between time to completion, number of regions trained, 
and the total number of metrics trained with both the z-scored absolute power and z-
scored coherence variables to determine if there was a need to control for any of these in 
subsequent analyses. Although a handful of metrics were significantly correlated, no 
patterns emerged across time, suggesting that neither time to completion nor the number 
of areas trained was significantly related to the effect of LORETA treatment. As such, 
these variables were not added as covariates to the analyses. 
The results of the independent samples t-test indicated that the two groups were 
equivalent at pretest on all (i.e., 49) z-score absolute power current densities, and on 141 
of the 147 z-score coherence current densities (see Tables 4.1 and 4.2). However, with 
147 comparisons, a Bonferroni correction was applied, after which none of the 
differences on the coherence metrics remained significant. Additionally, the random 
assignment research design allows for the assumption of probabilistic equivalence, 
suggesting that any differences at pretest are by chance. Thus, the two groups were 
equivalent at pretest on all qEEG metrics.  
Furthermore, while seven of the z-score absolute power and fourteen of the z-
score coherence variables violated the assumption of homogeneity of variance, 





sizes. As such, the discriminant analyses were run as described above. Similarly, the 
results of the pretest discriminant function analysis (DFA) further indicated that there 
were no significant differences at pretest for z-score absolute power, χ2(14) = 14.76, p ≥ 
.05, or coherence, χ2(14) = 9.98, p ≥ .05. 
Subsequent DFA indicated no significant group differences in z-score absolute 
power following session 10, χ2(14) = 8.65, p ≥ .05, or at post-test, χ2(14) = 19.23, p ≥ .05 
(see Table 4.3). This suggests that LORETA NF training had no effect on z-score 
absolute power. However, although each of the participants received z-score training in 
absolute power, previous research has suggested that NF training is more likely to result 
in changes in sensorimotor rhythm or power ratios than in absolute power (i.e., von 
Carlowitz-Ghori, et al., 2015). Additionally, coherence has been demonstrated to be a 
better predictor of cognitive ability (Thatcher, North, & Biver, 2005; Thatcher & Lubar, 
2009). Thus the z-score coherence analyses were of primary interest.  
Similar to the results of the z-score absolute power analyses, no significant group 
differences were found at session 10 for z-score coherence, χ2(14) = 21.28, p ≥ .05. 
However, following sessions 25, significant group differences were found, χ2(14) = 
23.73, p ≤ .05 (Table 4.4). This suggests that 10 sessions of LORETA NF was not 
sufficient to demonstrate change. As such, follow-up discriminant analyses were run to 
examine the dose-response relationship. Specifically, analyses were run to examine the 
differences between the maximum sham condition (i.e., session 10) and varying dosage 
strengths for the NF treatment condition—15, 20, and 25 sessions—in order to evaluate 
the number of sessions necessary to demonstrate this change. Additionally, since these 





The results of these planned comparisons suggest that 15 sessions, χ2(14) = 21.18, 
p ≥ .05 and 20 sessions, χ2(14) = 18.35, p ≥ .05 were not sufficient to demonstrate 
changes in coherence in the treatment group (see Table 4.5). Significant changes were 
again found in comparing the sham group at maximum placebo (i.e., session 10) to the 
NF group at maximum treatment (i.e.., session 25), χ2(14) = 24.22, p ≤ .05. This further 
suggests that 25 sessions is the minimum number of sessions of LORETA NF needed to 
demonstrate meaningful change in coherence, as the treatment group demonstrated a 
significant difference following 25 sessions when compared to the sham group, both prior 
to receiving treatment (i.e., max sham condition) and after receiving 5, 10, and 15 session 
of NF treatment themselves (i.e., delayed treatment). 
Furthermore, in exploring the standardized canonical coefficients resulting from 
these analyses, a pattern began to emerge. In comparing the two groups at post-test (i.e., 
following session 25), coherence between FP1 and FP2, and FP1-F3 differentiated the 
two groups across all hertz bands (i.e., delta, theta, alpha 1, alpha 2, beta 1, beta 2, and 
beta 3). In the follow-up DFA, the results were nearly identical (see Table 4.6). This 
suggests that 25 sessions of LORETA NF significantly affected the communication 
within the anterior prefrontal cortex (i.e., orbitofrontal cortex; Brodmann Area 10) with 
left lateralization within the dorsolateral prefrontal cortex (i.e., Brodmann Areas 8, 9).  
Behavioral Data  
 The results of the independent samples t-test indicated that the two groups—sham 
and treatment—were equivalent at pretest on all WJ measures. However, the two groups 
were not equivalent on 2 of the 3 CPT measures—omission errors and hit reaction time 





group at pretest, in spite of randomized group assignment, which likely impacted the 
results. Additionally, the CPT omission errors variable violated the assumption of 
homogeneity of variance at pretest, resulting in a need for non-parametric tests to 
examine group differences.  
Next, correlations were run to examine the relationship between the three short-
term/working memory measures. The results of the initial analysis indicated that while 
the WJ III scores at all three time-points were significantly correlated, the coefficients 
among the measures were lower than anticipated. Indeed, the highest correlation in the 
sample was numbers reversed at time 1 and time 2 (r = .84) suggesting heterogeneity in 
the sample could impact the results. Thus, factor analyses were completed to further 
examine the relationship between these three variables, which purportedly measure the 
same construct (see Table 4.8). Results indicated at pre-test there was one working 
memory factor comprising the three subtests fairly equally, for both for the sham 
(eigenvalue = 2.56) and treatment (eigenvalue = 2.13) groups. The same was found at 
mid-point for both groups (i.e., sham eigenvalue = 2.33; treatment eigenvalue = 2.13), 
indicating no significant overall group differences after the completion of 10 sessions. 
However, at post-test, the results indicated a single working memory factor for the sham 
group (eigenvalue = 2.26), and two distinct factors—working memory (eigenvalue = 
1.26) and short-term memory (eigenvalue = 1.02)—for the treatment group, suggesting a 
significant group difference in at least one of the subtests that makes up the composite. 
Additionally, the creation of a second factor for just the treatment group at time 3 
suggests that this difference is driven by the memory for words subtest, which makes up 





These results were not supported by a repeated measures multivariate analysis of 
variance (MANOVA; Table 4.9), indicating no difference between the treatment and 
control groups on numbers reversed, auditory working memory, and memory for words 
over time, F(6, 9) = 1.41, p = .31, partial η2 = .49.  Univariate tests also indicated there 
was no treatment effect on cognitive performance, for numbers reversed, F(2, 28) = 1.86, 
p = .18, partial η2 = .12, for auditory working memory F(2, 28) = 1.16, p = .33, partial η2 
= .08, or for memory for words, F(2, 28) = .08, p = .92, partial η2 = .006.  
Due to the differing results between the factor analysis and repeated measures 
MANOVA, a follow-up repeated-measures ANOVA (Table 4.10) was conducted for the 
memory for words subtest independently, using the “simple” contrast with the sham 
group as reference. The results indicated that group differences on this measure were in 
the expected direction, and approached significance, F(1, 14) = 4.27, p = .058, partial η2 
= .23. However, the study did not have sufficient power to find such an effect as 
evidenced by the observed power (.49) obtained through SPSS. The complete working 
memory analyses are included in Tables 4.8, 4.9, and 4.10. 
Correlations were run for the CPT data as well, indicating that the three CPT 
variables were not significantly related across time. As such, group differences on the 
CPT measures were examined using individual repeated measures ANOVAs. There was 
no statistically significant difference between the treatment and control group over time 
on either of the error measures: number of omission errors, F(2, 13) = .25, p = .78, partial 
η2 = .04 and number of commission errors, F(2, 13) = .1.93, p = .19, partial η2 = .23. 
However, the results of the omission errors ANOVA were not interpretable due to 





sphericity (Mauchly’s test: χ2(2) = 11.35, p =.003). As such Friedman’s test was run to 
examine group differences in omission errors. The results of the nonparametric test (i.e., 
Friedman) were similar, indicating that there was not an effect of neurofeedback on the 
number of omission errors made by participants, χ2(2) = 5.51, asymmetric p =.064. The 
effect of NF on hit reaction time approached significance, F(2, 13) = .3.71, p = .053, 
partial η2 = .37. However, post-hoc analysis using the “simple” contrast did not indicate a 
significant group difference over time, F(1, 14) = 2.99, p = .11 partial η2 = .18, 
suggesting that there is not an effect of neurofeedback on hit reaction time on the CPT.  
Results are included in Tables 4.11 and 4.12.  
Finally, no relationship was found between the number of areas trained and 
performance on the behavioral measures at any of the three time points. The highest 
correlation (r = -.26) found was for the number areas trained and memory for words 
performance at time 2. Additionally, only one behavioral metric (auditory working 
memory at time 2) was significantly correlated with time to completion (r = .59), though 






Table 4.1. Z-score Absolute Power Independent Samples T-Test at Pretest 
 
 
 Sham Treatment t-test Levene’s test Mann-Whitney 
U test 
 M (SD) M (SD) t (df = 14) p F p p 
D_FP1 -.83 (.64) -.82 (.66) -0.02 .99 0.09 0.78  
T_FP1 -.68 (.63) -.73 (.53) 0.15 .88 0.43 0.52  
A 1_FP1 -.54 (.60) -.63 (.66) 0.26 .80 0.04 0.85  
A 2_FP1 -.64 (.28) -.59 (.80) -0.17 .87 7.10 0.02* .88 
B 1_FP1 -.64 (.42) -.41 (1.09) -0.57 .58 5.36 0.04* .65 
B 2_FP1 -.59 (.73) -.20 (1.27) -0.75 .47 1.64 0.22  
B 3_FP1 -.16 (1.03) .32 (1.35) -0.80 .44 1.65 0.22  
D_FP2 -.92 (.61) -.58 (.67) -1.06 .31 0.23 0.64  
T_FP2 -.60 (.52) -.52 (.51) -0.30 .77 0.08 0.78  
A 1_FP2 -.53 (.57) -.58 (.65) 0.17 .87 0.06 0.82  
A 2_FP2 -.62 (.32) -.54 (.73) -0.27 .79 4.72 0.05* .96 
B 1_FP2 -.63 (.58) -.69 (.88) 0.14 .89 0.89 0.36  
B 2_FP2 -.60 (.81) -.57 (.97) -0.08 .94 0.001 0.97  
B 3_FP2 -.19 (.96) -.29 (.95) 0.21 .84 0.004 0.95  
D_F3 -.92 (.64) -.86 (.53) -0.19 .85 0.68 0.43  
T_F3 -.42 (.75) -.48 (.50) 0.18 .86 1.86 0.20  
A 1_F3 -.37 (.52) -.52 (.62) 0.52 .61 0.10 0.76  
A 2_F3 -.50 (.26) -.40 (.88) -0.31 .76 4.22 0.06  
B 1_F3 -.41 (.37) -.37 (1.05) -0.10 .92 3.92 0.07  
B 2_F3 -.43 (.62) -.35 (1.08) -0.19 .85 1.68 0.22  
B 3_F3 -.06 (.88) -.08 (.99) 0.03 .98 0.00 0.99  
D_F4 -.97 (.68) -.73 (.70) -0.70 .50 0.37 0.55  
T_F4 -.50 (.65) -.48 (.47) -0.08 .94 1.45 0.25  
A 1_F4 -.38 (.48) -.51 (.65) 0.43 .67 0.11 0.75  
A 2_F4 -.48 (.31) -.45 (.83) -0.09 .93 4.55 0.05  
B 1_F4 -.36 (.42) -.43 (1.04) 0.18 .86 3.19 0.10  
B 2_F4 -.40 (.57) -.31 (1.16) -0.19 .85 2.01 0.178  
B 3_F4 .07 (.98) -.04 (1.16) 0.20 .84 0.04 0.85  
D_F7 -1.21 (.52) -1.04 (.55) -0.64 .53 0.05 0.82  
T_F7 -.94 (.76) -1.02 (.46) 0.26 .80 1.92 0.19  
A 1_F7 -.58 (.64) -.85 (.70) 0.80 .44 0.02 0.89  
A 2_F7 -.72 (.34) -.80 (.86) 0.24 .82 4.98 0.04* .33 
B 1_F7 -.66 (.51) -.44 (1.3) -0.45 .66 4.79 0.05* 057 
B 2_F7 -.51 (.64) .21 (1.92) -1.00 .33 5.11 0.04* .80 
B 3_F7 -.09 (.03) .60 (2.12) -0.83 .42 3.65 0.08  
D_F8 -1.07 (.68) -.97 (.72) -0.31 .77 0.12 0.73  
T_F8 -.76 (.50) -.84 (.40) 0.33 .75 1.14 0.30  
A 1_F8 -.50 (.58) -.79 (.51) 1.04 .31 0.54 0.47  
A 2_F8 -.69 (.38) -.82 (.73) 0.46 .65 4.00 0.07  
B 1_F8 -.61 (.40) -.77 (.75) 0.54 .59 2.29 0.15  
B 2_F8 -.63 (.65) -.69 (.80) 0.15 .88 0.34 0.57  
B 3_F8 .08 (1.50) -.35 (1.17) 0.64 .53 1.33 0.27  
D_Fz -.96 (.65) -.80 (.65) -0.49 .63 0.26 0.62  
T_Fz -.49 (.60) -.44 (.54) -0.17 .86 0.74 0.40  
A 1_Fz -.36 (.47) -.46 (.58) 0.39 .70 0.04 0.84  
A 2_Fz -.46 (.26) -.41 (.78) -0.18 .86 5.71 0.03* .80 
B 1_Fz -.37 (.40) -.45 (.82) 0.26 .80 1.00 0.33  
B 2_Fz -.41 (.70) -.56 (.70) 0.41 .69 0.1 0.93  
B 3_Fz .16 (1.40) -.15 (1.03) 0.50 .63 1.58 0.23  
Note. N = 8 per group. *p  .05. D = delta, T = theta, A1 = alpha 1, A2 = alpha 2, B1 = 
beta 1, B2 = beta 2, B3= beta 3. Independent samples Mann-Whitney U test used to 





Table 4.2. Z-score Coherence Independent Samples T-Test at Pretest 
 
 
 Sham  Treatment 
 
t-test Levene’s test Mann-Whitney  
U test 
 M (SD) M (SD) t df p F p  
D_FP1_FP2 -.19 (1.48) -.68 (1.32) .69 14 .50 .02 .88  
T_FP1_FP2 -.03 (1.72) -.21 (.64) .28 14 .78 1.74 .21  
A 1_FP1_FP2 .28 (.79) -.17 (.80) 1.13 14 .28 .12 .73  
A 2_FP1_FP2 .22 (.63) -.24 (1.03) 1.06 14 .31 1.57 .23  
B 1_FP1_FP2 .21 (1.08) -.33 (1.02) 1.02 14 .32 .003 .96  
B 2_FP1_FP2 .13 (1.14) -.39 (1.18) .90 14 .38 .26 .62  
B 3_FP1_FP2 .3 (1.25) -.21 (1.29) .38 14 .71 .03 .87  
D_FP1_F3 .25 (.86) .02 (.58) .62 14 .55 .54 .48  
T_FP1_F3 .52 (.92) .20 (.39) .91 14 .38 6.04 .03* .72 
A 1_FP1_F3 .21 (.87) -.18 (.33) 1.18 14 .26 4.03 .07  
A 2_FP1_F3 .09 (.90) -.45 (1.09) 1.09 14 .29 .77 .39  
B 1_FP1_F3 .30 (1.04) -.76 (1.47) 1.65 14 .12 3.43 .09  
B 2_FP1_F3 .18 (1.33) -1.07 (1.8) 1.58 14 .14 3.10 .10  
B 3_FP1_F3 .21 (1.08) -.48 (1.27) 1.17 14 .26 .98 .34  
D_FP1_F4 .04 (1.59) -.19 (.97) .34 14 .74 .37 .55  
T_FP1_F4 .32 (1.43) -.12 (.62) .81 14 .43 7.91 .01* .88 
A 1_FP1_F4 .23 (.81) -.260 (.37) 1.55 14 .14 8.34 .01* .44 
A 2_FP1_F4 .12 (.72) -.22 (.79) .90 14 .38 .62 .44  
B 1_FP1_F4 .16 (1.13) -.68 (1.4) 1.33 14 .21 .82 .38  
B 2_FP1_F4 .20 (1.11) -1.04 (1.71) 1.72 14 .11 3.43 .09  
B 3_FP1_F4 -.22 (1.21) -.62 (1.48) .59 14 .56 1.33 .27  
D_FP1_F7 -.05 (.95) .03 (.49) -.22 14 .83 2.70 .12  
T_FP1_F7 .16 (.59) .02 (.32) .62 14 .54 4.76 .05* .65 
A 1_FP1_F7 -.05 (.73) -.35 (.44) 1.01 14 .33 1.35 .27  
A 2_FP1_F7 -.52 (0.5) -0.550.56 .14 14 .89 .10 .76  
B 1_FP1_F7 -.17 (.81) -.83 (1.39) 1.15 14 .27 .83 .38  
B 2_FP1_F7 -.24 (1.57) -1.31 (1.42) 1.42 14 .18 .02 .88  
B 3_FP1_F7 -.12 (1.38) -1.0 (1.46) 1.24 14 .24 .007 .94  
D_FP1_F8 .30 (1.25) -.22 (.92) .95 14 .36 .51 .49  
T_FP1_F8 .66 (1.19) -.09 (.70) 1.55 14 .14 2.83 .12  
A 1_FP1_F8 .34 (.91) -.29 (.740 1.51 14 .15 1.52 .24  
A 2_FP1_F8 .25 (.55) -.18 (.71) 1.34 14 .20 .02 .88  
B 1_FP1_F8 .26 (1.06) -.45 (.85) 1.49 14 .16 .69 .42  
B 2_FP1_F8 -.08 (1.04) -.65 (1.14) 1.04 14 .32 .43 .52  
B 3_FP1_F8 -.53 (1.4) -.70 (1.25) .26 14 .80 .003 .96  
D_FP1_Fz -.12 (1.99) -.28 (0.75) .21 14 .83 1.86 .19  
T_FP1_Fz .46 (1.38) .04 (.65) .80 14 .45 5.56 .03* .80 
A 1_FP1_Fz .24 (.90) -.16 (.32) 1.19 14 .26 4.85 .05* .23 
A 2_FP1_Fz .20 (.74) -.16 (.92) .87 14 .40 .35 .56  
B 1_FP1_Fz .33 (1.06) -.42 (1.06) 1.43 14 .18 .35 .56  
B 2_FP1_Fz .28 (1.14) -.82 (1.4) 1.71 14 .11 2.26 .16  
B 3_FP1_Fz .06 (1.290 -.66 (1.46) 1.05 14 .31 .93 .35  
D_FP2_F3 0 (1.15) -.71 (1.42) 1.09 14 .29 .46 .51  
T_FP2_F3 .46 (1.21) -.18 (.61) 1.34 14 .20 1.79 .20  
A 1_FP2_F3 .27 (.81) -.13 (.56) 1.14 14 .28 2.88 .11  
A 2_FP2_F3 .23 (.54) -.21 (.71) 1.42 14 .18 1.42 .25  
B 1_FP2_F3 .42 (.70) -.25 (.97) 1.59 14 .14 .79 .39  
B 2_FP2_F3 .24 (.95) -.35 (1.38) 1.00 14 .34 1.28 .28  
B 3_FP2_F3 -.02 (1.13) -.33 (1.34) .51 14 .62 1.12 .31  
D_FP2_F4 .49 (1.28) -.30 (1.5) 1.14 14 .27 .84 .38  
T_FP2_F4 .55 (1.28) .24 (.56) .63 14 .54 1.76 .21  
A 1_FP2_F4 .46 (.45) .06 (.31) 2.02 14 .06 .57 .46  
A 2_FP2_F4 .34 (.52) -.05 (.77) 1.20 14 .25 1.66 .22  
B 1_FP2_F4 .36 (.87) -.31 (.26) 1.23 14 .24 1.88 .19  





B 3_FP2_F4 .02 (1.36) -.28 (1.29) .46 14 .66 .05 .83  
D_FP2_F7 -.20 (1.03) -.90 (.95) 1.40 14 .18 .03 .88  
T_FP2_F7 -.12 (1.04) -.62 (.46) 1.25 14 .23 4.99 .04* .23 
A 1_FP2_F7 -.03 (.65) -.51 (.59) 1.55 14 .14 .39 .54  
A 2_FP2_F7 -.46 (.39) -.48 (.52) .09 14 .93 1.06 .32  
B 1_FP2_F7 -.25 (.86) -.73 (.59) 1.28 14 .22 1.78 .20  
B 2_FP2_F7 -.17 (1.11) -.81 (1.08) 1.19 14 .26 .09 .77  
B 3_FP2_F7 -.37 (1.29) -.52 (.98) .27 14 .79 1.23 .28  
D_FP2_F8 .72 (1.01) -.09 (.95) 1.65 14 .12 .16 .69  
T_FP2_F8 .82 (.74) 0.470.32 1.20 14 .25 3.42 .09  
A 1_FP2_F8 .59 (.59) .09 (.48) 1.84 14 .09 .12 .74  
A 2_FP2_F8 .47 (.33) .07 (.66) 1.50 14 .16 1.66 .22  
B 1_FP2_F8 .44 (0.72) -.13 (1.06) 1.27 14 .22 1.44 .25  
B 2_FP2_F8 .22 (.77) -.15 (1.2) .74 14 .47 3.58 .08  
B 3_FP2_F8 .06 (.76) -.21 (1.24) .52 14 .61 4.18 .06  
D_FP2_Fz .19 (1.33) -.79 (1.66) 1.31 14 .21 .99 .34  
T_FP2_Fz .54 (1.54) -.07 (.59) 1.05 14 .31 2.85 .11  
A 1_FP2_Fz .40 (.71) .06 (.36) 1.19 14 .25 3.63 .08  
A 2_FP2_Fz .43 (.58) -.04 (.62) 1.55 14 .14 .03 .87  
B 1_FP2_Fz .46 (.70) -0.12 .79 1.58 14 .14 .74 .41  
B 2_FP2_Fz .25 (.82) -.15 (1.13) .82 14 .43 .77 .40  
B 3_FP2_Fz .12 (1.04) -.11 (1.05) .45 14 .66 .05 .83  
D_F3_F4 .41 (.77) .21 (.52) .59 14 .56 1.00 .33  
T_F3_F4 .54 (.54) .04 (.48) 1.92 14 .08 .84 .38  
A 1_F3_F4 .22 (.69) -.09 (.53) 1.01 14 .33 2.65 .13  
A 2_F3_F4 .16 (.47) -.13 (.75) .92 14 .37 1.53 .24  
B 1_F3_F4 .21 (.63) -.23 (1.03) 1.03 14 .32 .38 .55  
B 2_F3_F4 .39 (.69) -.48 (1.76) 1.31 14 .21 1.41 .25  
B 3_F3_F4 -.17 (.89) -.18 (1.09) .008 14 .99 .07 .80  
D_F3_F7 .50 (.57) .09 (.30) 1.84 14 .09 5.72 .03* .20 
T_F3_F7 .45 (.52) .10 (.21) 1.77 14 .10 7.38 .017* .16 
A 1_F3_F7 .12 (.55) -.49(.44) 2.46 14 .03* .20 .66  
A 2_F3_F7 -.17 (.62) -.53 (.61) 1.16 14 .27 .06 .81  
B 1_F3_F7 .28 (.60) -.81 (1.38) 2.05 14 .06 6.38 .02* .16 
B 2_F3_F7 .10 (.99) -1.53 (2.07) 2.00 14 .07 8.77 .01* 08 
B 3_F3_F7 .09 (.98) -.93 (1.61) 1.53 14 .15 11.03 .005* .16 
D_F3_F8 .21 (.90) -.29 (.67) 1.27 14 .23 .66 .43  
T_F3_F8 .77 (.82) -.19 (.71) 2.50 14 .03* .41 .53  
A 1_F3_F8 .27 (.86) -.32 (.77) 1.45 14 .17 .41 .53  
A 2_F3_F8 .21 (.46) -.27 (.66) 1.70 14 .11 .42 .53  
B 1_F3_F8 .41 (.89) -.39 (.65) 2.07 14 .06 3.08 .10  
B 2_F3_F8 .21 (.67) -.63 (1.30) 1.62 14 .13 3.81 .07  
B 3_F3_F8 -.25 (1.16) -.57 (1.21) .53 14 .60 .33 .58  
D_F3_Fz .56 (.44) .54 (.28) .13 14 .90 2.09 .17  
T_F3_Fz .61 (.40) .43 (.28) 1.07 14 .30 2.41 .14  
A 1_F3_Fz .26 (.68) .13 (.49) .45 14 .66 .49 .50  
A 2_F3_Fz .38 (.32) .15 (.50) 1.09 14 .29 .55 .47  
B 1_F3_Fz .52 (.22) .24 (.49) 1.44 14 .17 1.27 .28  
B 2_F3_Fz .57 (.32) -.13 (1.24) 1.54 14 .15 2.55 .13  
B 3_F3_Fz .30 (.71) .07 (.81) .61 14 .55 .18 .68  
D_F4_F7 .17 (.67) -.54 (.70) 2.09 14 .06 .39 .54  
T_F4_F7 .18 (1.01) -.56 (.59) 1.79 14 .10 2.21 .16  
A 1_F4_F7 .03 (.70) -.58 (.63) 1.82 14 .09 .15 .71  
A 2_F4_F7 -.45 (.42) -.55 (.71) .36 14 .73 1.36 .26  
B 1_F4_F7 -.14 .(82) -.94 (.70) 2.10 14 .05 .10 .75  
B 2_F4_F7 .04 (1.17) -1.611.51 2.44 14 .03* 1.19 .29  
B 3_F4_F7 -.39 (1.03) -.94 (1.25) .95 14 .36 1.01 .33  
D_F4_F8 .61 (.74) .40 (.37) .70 14 .50 1.79 .20  
T_F4_F8 .83 (.63) .39 (.44) 1.64 14 .12 .80 .39  
A 1_F4_F8 .54 (.65) -.01 (.57) 1.78 14 .10 .04 .84  
A 2_F4_F8 .48 (.39) -.12 (.74) 2.05 14 .06 5.86 .03* .28 





B 2_F4_F8 .06 (.95) -.60 (1.64) .98 14 .34 2.18 .16  
B 3_F4_F8 -.04 (1.39) -.51 (1.41) .68 14 .51 .17 .69  
D_F4_Fz .59 (.46) .40 (.29) 1.01 14 .33 .11 .74  
T_F4_Fz .62 (.38) .25 (.32) 2.08 14 .06 .71 .41  
A 1_F4_Fz .39 (.53) .13 (.39) 1.10 14 .29 2.33 .15  
A 2_F4_Fz .27 (.48) -.06 (.64) 1.17 14 .26 .82 .38  
B 1_F4_Fz .09 (1.1) -.22 (.95) .61 14 .55 .12 .75  
B 2_F4_Fz -.18 (1.85) -.58 (2.04) .41 14 .69 .02 .89  
B 3_F4_Fz -.42 (1.47) -.33 (1.28) -.13 14 .90 .04 .84  
D_F7_F8 .10 (.88) -.94 (.89) 2.35 14 .03* .08 .78  
T_F7_F8 .45 (1.01) -.73 (.76) 2.65 14 .02* .82 .38  
A 1_F7_F8 .08 (.72) -.67 (.78) 1.98 14 .07 .03 .87  
A 2_F7_F8 -.37 (.38) -.61 (.53) 1.05 14 .31 .37 .55  
B 1_F7_F8 .03 (.88) -.70 (.36) 2.17 14 .05* 10.20 .007* .16 
B 2_F7_F8 -.19 (.98) -.89 (.69) 1.64 14 .12 .53 .48  
B 3_F7_F8 -.26 (.65) -.75 (.73) 1.43 14 .18 1.33 .27  
D_F7_Fz .27 (.58) -.43 (.62) 2.32 14 .04* .04 .84  
T_F7_Fz .27 (.96) -.39  (.62) 1.63 14 .13 3.80 .07  
A 1_F7_Fz -.03 (.72) -.61 (.59) 1.77 14 .10 1.11 .31  
A 2_F7_Fz -.50 (.53) -.61 (.68) .36 14 .73 .21 .66  
B 1_F7_Fz -.06 (.74) -.88 (.97) 1.91 14 .08 .87 .37  
B 2_F7_Fz -.04 (1.2) -1.74 (1.48) 2.52 14 .02* 1.56 .23  
B 3_F7_Fz -.27 (.88) -1.13 (1.45) 1.44 14 .17 4.52 .05  
D_F8_Fz .37 (.81) -.04 (.53) 1.20 14 .25 .87 .37  
T_F8_Fz .81 (.92) .02 (.54) 2.09 14 .06 3.83 .07  
A 1_F8_Fz .39 (.87) -.13 (.63) 1.37 14 .19 1.64 .22  
A 2_F8_Fz .38 (.54) -.26 (.66) 2.14 14 .05 .006 .94  
B 1_F8_Fz .41 (.94) -.37 (.65) 1.91 14 .08 1.72 .21  
B 2_F8_Fz .03 (.73) -.58 (1.14) 1.28 14 .22 2.04 .18  
B 3_F8_Fz -.22 (.99) -.49 (.97) .55 14 .59 .17 .69  
Note. N = 8 per group. *p  .05. D = delta, T = theta, A1 = alpha 1, A2 = alpha 2, B1 = 
beta 1, B2 = beta 2, B3= beta 3. Independent samples Mann-Whitney U test used to 





Table 4.3. Z-score Absolute Power  
Discriminant Function Analyses 
 
 
 Wilk’s  χ
2 (df) p 
Pre-test .12 14.76 (14) .40 
Session 10 .29 8.65 (14) .85 
Post-test .06 19.23 (14) .16 





Table 4.4. Z-score Coherence  
Discriminant Function Analyses 
 
 
 Wilk’s  χ
2 (df) P 
Pre-test .24 9.98 (14) .76 
Session 10 .05 21.28 (14) .10 
Post-test .03 23.73 (14) .05* 






Table 4.5. Dose-Response Z-score  
Coherence Discriminant Function Analyses 
 
 
 Wilk’s  χ
2 (df) p 
Session 15 .05 21.18 (14) .10 
Session 20 .07 18.35 (14) .19 
Post-test .03 24.22 (14) .04* 





Table 4.6. Standardized Canonical Discriminant Function Coefficients 
 
 
 Post-test Analysis Dose Response Analysis 
D_FP1_FP2 1.139 -5.872 
T_FP1_FP2 4.788 2.709 
A 1_FP1_FP2 -9.041 2.334 
A 2_FP1_FP2 3.989 -10.508 
B 1_FP1_FP2 -1.223 15.314 
B 2_FP1_FP2 .306 -11.792 
B 3_FP1_FP2 1.727 6.472 
D_FP1_F3 .247 18.616 
T_FP1_F3 -.227 -8.059 
A 1_FP1_F3 2.453 -10.128 
A 2_FP1_F3 2.041 7.238 
B 1_FP1_F3 -.236 -17.204 
B 2_FP1_F3 2.796 8.269 
B 3_FP1_F3 -3.537  
A 1_FP1_F4  4.677 
Note. D = delta, T = theta, A1 = alpha 1, A2 = alpha 2,  








Table 4.7.  Independent Samples T-Test at Pretest for Behavioral Data 
   t-test Levene’s test 
 Sham Condition 
M (SD) 
Treatment Condition  
M (SD) 
t (df) p F p 
Numbers Reversed 100.75  (12.08) 99.13 (15.39) .24 (14) .82 .27 .62 
Auditory Working Memory 105.88 (13.44) 109.250 (12.75) -.51 (14) .61 .04 .85 
Memory for Words 99.25 (9.74) 106.75 (12.14) -1.36 (14) .19 .73 .41 
Omissions 43.85 (2.75) 51.1075 (6.23) -3.02 (14) .009* 6.31 .03* 
Commissions 59.04 (10.73) 55.1462 (8.02) .82 (14) .43 1.90 .19 
Hit Reaction Time 36.26 (6.86) 48.078 (9.19) -2.92 (14) .01* .46 .51 





Table 4.8. Factor Analysis of Working Memory Measures 
 
 
 Component 1 Component 2 
Model 1a   
Numbers Reversed .948  
Auditory Working Memory .904  
Memory for Words .921  
Model 1b   
Numbers Reversed .927  
Auditory Working Memory .809  
Memory for Words .787  
   
Model 2a   
Numbers Reversed 880  
Auditory Working Memory .926  
Memory for Words .833  
Model 2b   
Numbers Reversed .927  
Auditory Working Memory .809  
Memory for Words .787  
   
Model 3a   
Numbers Reversed .899  
Auditory Working Memory .860  
Memory for Words .843  
Model 3b   
Numbers Reversed .808 066 
Auditory Working Memory .717 -.451 
Memory for Words .299 .903 
Note. Extraction Method: Principal Components Analysis.   
Model 1a = sham group at pretest, Model 1b = NF group at pretest,  
Model 2a = sham group following session 10, Model 2b = NF  
group following session 10, Model 3a = sham group at post-test,  






Table 4.9. Repeated Measures MANOVA for Working Memory Measures 
 
 
Effect Wilk’s  F (df) p Observed Power 
Between Subjects      
 Intercept .004 976.10 (3, 
12) 
.000**  
 Condition .65 2.18 (3, 12) .14 .42 
Within Subjects      
 Time .16 7.68 (6, 9) .84  
 Time*Condition .52 1.41 (6, 9) .31 .31 





Table 4.10. Post Hoc Analysis with Simple Contrast: Memory for Words 
 
 
 Sums of Squares F (df) p Observed Power 
Contrast  240.25 4.27 (1, 14) .058 .49 
Error 788.39    





Table 4.11. CPT Repeated Measures ANOVAs 
 
 
 Wilk’s  F (df) p Observed Power 
Omission Errors^ .96 .25 (2, 13) .78 .08 
Commission Errors .77 1.93 (2, 13) .19 .33 
Hit Reaction Time .64 3.71 (2, 13) .053 .57 
Note.^ Uninterpretable due to violation of homogeneity of variance.  





Table 4.12. Post Hoc Analysis with Simple Contrast: Hit Reaction Time 
 
 
 Sums of Squares F (df) p Observed Power 
Contrast  281.01 2.99 (1, 14) .11 .36 
Error 1314.68    







It was hypothesized that the two groups would not exhibit significant differences 
at pre-test, the group differences would be greatest at the mid-treatment time point (i.e., 
session 10), prior to the control group receiving the treatment, and at post-test, the groups 
would begin to demonstrate similar scores again, due to the nature of the delayed 
treatment design.  
The first hypothesis was generally supported, as the groups were equivalent at 
pretest for the z-score absolute power and z-score coherence metrics.  Results from the 
behavioral analyses similarly indicated no significant group differences at pretest for 4 of 
the 6 behavioral measures. Additionally, although the sham group outperformed the 
treatment group at pretest, by chance, the scores on the omission errors measure were 
within the average range for both groups, further suggesting approximate group 
equivalence. The sham group’s faster reaction time is also likely related to the number of 
commission errors, which was equivalent across groups. Finally, due to random 
assignment and equal group sizes, the study can assume probabilistic equivalence. 
The second hypothesis was not supported by the either the qEEG or behavioral 
analyses as there were no significant group differences following 10 NF sessions. As 
such, the results of this study are consistent with the current literature base, suggesting 
that 10 sessions of training is not sufficient to demonstrate significant change. 





(Arns et al., 2009; Holtmann, et al., 2009, Holtmann, et al., 2014) are necessary for 
surface NF, though it is hypothesized that LORETA NF can demonstrate faster change 
(Simkin, Thatcher, & Lubar, 2014; Wigton & Krigbaum, 2014). However, the results of 
this study suggest that 10 sessions of LORETA NF is still insufficient to demonstrate 
meaningful change on either a qEEG metric, or on behavioral measures of cognitive 
ability.  
The third hypothesis was that at post-test, the sham group would begin to 
demonstrate change in the same direction as the treatment group. This hypothesis was 
partially supported. First, the qEEG analyses demonstrated significant change between 
groups at session 25, for the z-score coherence metric. Additionally, while both groups 
improved on the behavioral measures over time, the groups began to demonstrate 
significant between-group differences at post-test, particularly on the verbal working 
memory measure—memory for words—which approached significance, but was 
underpowered. Furthermore, the factor analytic examination of the working memory data 
supports the existence of group differences on the memory for words subtest, due to the 
change in factor structure (i.e., emergence of a second factor for that subtest for only the 
treatment group, at posttest). 
Further examination of the qEEG data, by comparing the maximum placebo effect 
(i.e., sham group at session 10) with the treatment group at differing points of treatment 
allowed for an approximation of a dose-response relationship (i.e., hypothesis 4). This 
post-hoc analysis further supported the finding that 25 sessions of LORETA NF was 





Finally, in examining the canonical coefficients from the discriminant analyses, 
coherence within the prefrontal cortex—bilaterally within the left and right orbitofrontal 
cortex (i.e., Brodmann Area 10) and between the left orbitofrontal cortex and left 
dorsolateral prefrontal cortex—was where the most drastic changes occurred. The 
prefrontal cortex is involved with cognitive control, and the secondary left lateralization 
suggests possible implications for language. Memory for words is a verbal working 
memory measure. The behavioral analyses approached significance, and though not 
statistically significant in this study, the changes were in the expected direction, and more 
importantly, the results were consistent with the qEEG changes in coherence. 
Overall, results of this study suggest that 25 sessions of LORETA NF training is 
needed to demonstrate meaningful changes in a college-aged ADHD population, which is 
consistent with previous literature. Additionally, the consistency between the qEEG and 
behavioral data is also consistent with previous research, suggesting the importance of 
the left prefrontal cortex in the acquisition and maintenance of one’s verbal working 
memory.  
Limitations 
This study has a number of limitations. First, and foremost, the small sample size 
is a major limitation. Although the a priori power analyses suggested that the study was 
sufficiently powered, these analyses were run for univariate models, not multivariate. As 
such the small sample size, and small effect sizes likely contributed to the lack of 
significant findings. However, the emergence of a second WJ factor, as well as the results 
of the post-hoc ANOVA  contrast suggests that the results are in the expected direction, 





Some of the outcome measures were also not ideal for this population. Although 
the WJ-III Tests of Cognitive Abilities has excellent psychometric properties, it is better 
at demonstrating developmental change (i.e., within a school-age population). This was 
determined following the completion of phase 1 of the study, as many of the participants 
exhibited a ceiling effect (i.e., scored near the maximum score prior to post-test). As 
such, it is likely that the use of a different measure, one meant specifically for adults, 
could have provided a better measure of change over time for working memory.  
Previous research has also suggested that individuals with ADHD are highly 
motivated by immediate, and personally salient rewards (Marco, et al., 2009). Subjective 
report from the participants indicated that the stimuli used in the study were boring. In 
fact, several participants requested to change their chosen stimuli part way through the 
study, suggesting that they were no longer interested in the stimuli, and thus less likely to 
maintain focus. The payment scale also seemed to be too far spread out. Future studies 
should consider more frequent, smaller payments (i.e., $5 at the end of every session). 
Although the larger sums seem like a greater reward, it is possible that this smaller, 
consistent reward would be more meaningful, and thus help to improve the outcome(s).  
Finally, this began as an efficacy study, to evaluate the efficacy of LORETA NF 
for the treatment of ADHD in a college population. However, there was significant 
attrition, and participant’s treatment compliance was inconsistent. For instance, 
participants were asked to complete 2-3 sessions weekly for a duration of approximately 
3 months, yet the average time to completion was 5.34 months. Additionally, one 
participant took 11 months to complete the study, and another took 14 months, likely 





reported inconsistency in their regular stimulant medication regime, and 2 others changed 
their dosage and/or the prescribed stimulant during the study. Although attempts were 
made to control for this, it became too cumbersome with the sheer volume of variables. 
Finally, at the completion of the study 2 participants acknowledged that they 
recreationally used marijuana at some point during the study, and 1 participant attempted 
to quit smoking during the study, which could have further impacted the results. As such, 
what began as an efficacy study became more of an effectiveness study, demonstrating 
that a college campus is likely not the best environment for LORETA NF treatment. 
However, in spite of these challenges, the results were still within the expected direction, 
providing even stronger support for the use of this treatment within a clinical setting.   
Implications 
Although the group level behavioral analyses for this study were not statistically 
significant, the results are in the expected direction, and consistent with the qEEG 
coherence results. Additionally, the results are consistent with other recent studies in the 
field, suggesting that NF is an effective and appropriate intervention for individuals with 
ADHD. Furthermore, this study is one of very few investigating the impact of NF 
training with a college population, thus filling a much-needed gap in the literature. 
Finally, the results of this study provide support for the use of LORETA NF with a 
college-aged population with ADHD, and more importantly, demonstrate the need for 25 
sessions of LORETA NF to truly affect change. Although there is hope for NF LORETA 
to enable faster change, the results of this study suggest that a large number of sessions 





the 30-50 sessions reported in other studies of surface NF, suggesting that perhaps 
LORETA NF is more efficient.  
Future Directions 
 Given the significant limitations to this study, further investigation is needed to 
examine the efficacy and effectiveness of NF training for the treatment of ADHD in a 
college population. Future studies should include a larger sample size, and stricter 
inclusion criteria, specifically that participants must agree to a schedule of 2-3 weekly 
sessions prior to their first session. Additionally, future studies should examine more 
closely the dose-response relationship in order to more fully answer the question of 
whether LORETA NF is a faster and more efficient means of affecting change for young 
adults with ADHD. Lastly, given the heterogeneity of ADHD, specifically the vast 
differences in symptomatology and onset of ADHD-predominately inattentive type, 
future studies should examine the effects of LORETA NF training on the distinct 
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Prior to 1st visit: 
screening 
Online screener (including demographics, assessment 
measures) 
1st visit: baseline  
(pre-test) 
Baseline EEG data collection, pretest measures, begin 
neurofeedback or sham condition 
2nd – 10th visits Continue neurofeedback or sham condition 
10th visit (1st post-test) Re-administer outcome measures 
11th-25th visits All subjects getting neurofeedback 
25th visit: post-test data 
collection 





ONLINE DEMOGRAPHIC SCREENER SURVEY 
 
OVERVIEW 
What is "neurofeedback"? 
Neurofeedback = EEG biofeedback = The process of changing brain functioning/ 
“moving” the brain toward a healthier state by using operant conditioning methods. This 
is similar to "rewarding" your brain waves for firing at a target rate...like training your 
brain. 
Why do neurofeedback with students with ADHD? 
We want to investigate whether neurofeedback is effective in changing functioning in 
brain areas associated with ADHD. For example, there is previous research to suggest 
large effect sizes for neurofeedback reducing impulsivity and hyperactivity in children 
with ADHD (Arns de Ridder et al., 2009). We want to build on this previous research. 
What do I get out of this? 
1. Up to 3 hours of SONA credit (for completion of screening measures and the first 
visit). 
2. $125 in cash (for completion of all 25 sessions. The first 10 sessions must be 
completed within 4 weeks, ideally 2-3 sessions per week for the duration of the study). 
3. You will be provided with a snapshot report of your brain activity over the sessions. 
 
What will be required of you? 
1. Complete a brief online screening to determine eligibility and you may be asked to 




2. Visit the ACN lab for 25 total neurofeedback sessions ranging from 30 minutes to 2 
hours each (the first and last sessions will be the longest) 
    a. Capping: each session, the research team will fit you with an EEG cap. This is not 
invasive, but does include application of saline gel to the scalp. 
    b. Fill out forms and answer questions about how you are feeling after receiving 
neurofeedback (each session) 
    c. At the first and last sessions, perform an attention task on the computer, and 
complete some measures of cognitive ability. 
    d. You must complete all 25 sessions. Sessions are made by appointment and if you are 
unable to make the appointment, you will need to give 24 hours’ notice. (Two no-shows 
is grounds for dismissal without compensation.) 
 
CLICK HERE IF YOU ARE INTERESTED IN SEEING IF YOU ARE ELIGIBLE... 
ACN Lab Neurofeedback Study 
Please complete all of the information below to the best of your ability. All information 
will be kept confidential. 
 
* Required 
First and Last Name*  
Email Address*  
Age in Years*  









Who gave you this diagnosis?* 










Please list all medications you currently take, including those for ADHD. Include dosage 
and frequency (e.g., daily, twice daily, etc.)* 
 
 
Please list any other current diagnoses (e.g., depression, anxiety). If applicable, include 
the type of treatment. * 
 










Current Symptoms Scale 
 
For the following questions, please select the answer that best describes your behavior 
DURING THE PAST 6 MONTHS. 
 
Fail to give close attention to details or make careless mistakes in my work*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
Fidget with hands or feet or squirm in seat*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
Have difficulty sustaining my attention in tasks or fun activities. *  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
Leave my seat in situations in which seating is expected*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
Don't listen when spoken to directly*  
0) Never or Rarely  
1) Sometimes  
2) Often  




Feel restless*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
 
Don't follow through on instructions and fail to finish work*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
Have difficulty engaging in leisure activities or doing fun things quietly*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
Have difficulty organizing tasks and activities*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
Feel "on the go" or "driven by a motor"*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
Avoid, dislike, or am reluctant to engage in work that requires sustained mental 
effort.*  
0) Never or Rarely  
1) Sometimes  
2) Often  





Talk excessively*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
Lose things necessary for tasks or activities*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
Blurt out answers before questions have been completed*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
Am easily distracted*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
Have difficulty awaiting turn*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
Am forgetful in daily activities*  
0) Never or Rarely  
1) Sometimes  
2) Often  





Interrupt or intrude on others*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
 
How old were you when these problems with attention, impulsiveness or 
hyperactivity first began to occur?*  
 
  
To what extent do the problems you may have checked above interfere with your ability to 
function in each of these areas of life activities? 
 
In my home life with my immediate family*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
In my work or occupation*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
In my social interactions with others*  
0) Never or Rarely  
1) Sometimes  
2) Often  




In activities or dealings in the community*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
In any educational activities*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
 
In my dating or marital relationship*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
In my management of my money*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
In my driving of a motor vehicle*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
In my leisure or recreational activities*  
0) Never or Rarely  
1) Sometimes  
2) Often  




In my management of my daily responsibilities *  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
Instructions: Again, please check the number next to each item that best describes your 
behavior DURING THE PAST 6 MONTHS. 
 
Lose temper *  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
Argue*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
Actively defy or refuse to comply with requests or rules*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
Deliberately annoy people*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
Blame others for my mistakes or behavior*  
0) Never or Rarely  
1) Sometimes  
2) Often  





Am touchy or easily annoyed by others*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
 
Am angry or resentful*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
 
Am spiteful or vindictive*  
0) Never or Rarely  
1) Sometimes  
2) Often  
3) Very Often  
 
Impulsivity Scale 
People differ in the ways they act and think in different situations. This is a test to 
measure some of the ways in which you act and think. Read each statement and check the 
box next to the appropriate response. Do no spend too much time on any statement. 
Answer quickly and honestly. 
 
I plan tasks carefully*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I do things without thinking*  
1) Rarely/Never  
2) Occasionally  
3) Often  




I make-up my mind quickly*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I am happy-go-lucky*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I don't "pay attention"*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I have "racing" thoughts*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I plan trips well ahead of time*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I am self-controlled*  
1) Rarely/Never  
2) Occasionally  
3) Often  




I concentrate easily*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I save regularly*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I "squirm" at plays or lectures*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I am a careful thinker*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I plan for job security*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I say things without thinking*  
1) Rarely/Never  
2) Occasionally  
3) Often  




I like to think about complex problems*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I change jobs*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I act "on impulse"*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I get easily bored when solving thought problems*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I act on the spur of the moment*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I am a steady thinker*  
1) Rarely/Never  
2) Occasionally  
3) Often  




I change residences*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I buy things on impulse*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I can only think about one thing at a time*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I change hobbies*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I spend or change more than I earn*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I often have extraneous thoughts when thinking*  
1) Rarely/Never  
2) Occasionally  
3) Often  




I am more interested in the present than the future*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I am restless at the theater or lectures*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
I like puzzles*  
1) Rarely/Never  
2) Occasionally  
3) Often  
4) Almost Always/Always  
 
I am future oriented*  
1) Rarely/Never  
2) Occasionally  
3) Often  










SUBJECTIVE CHANGE INDEX 
Please indicate if you have noticed any changes in any of the following areas 
since starting this study. Use the following rating scale for each area. Place an X 
in the appropriate box that best represents of change in different areas.  
 
Rating Scale 
0   No Change 
1   Maybe a little change 
2   Some Change 
3   Definitely some change 
4   Definitely moderate amount of change 
5   Definitely a large amount of change  
 
 0 1 2 3 4 5 
Positive 
Emotions 
      
Negative 
Emotions 
      
Attention 
Concentration 
      
Body 
Awareness 
      
Body 
Movement 
      
Visual 
Perception 
      
Auditory 
Perception 
      
Language 
 
      
Thinking 
 
      
Memory 
 
      
Anxiety 
 
      
Sadness 
 




In your opinion do you feel there was a relationship or connection between what 
you were thinking and the feedback you were receiving on the screen? 
 
 
Please Circle your Answer: 
 




2 Probably Not 
 
3 Definitely Not 
 
 
 
 
 
 
 
 
 
 
